<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Immunol.</journal-id>
<journal-title>Frontiers in Immunology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Immunol.</abbrev-journal-title>
<issn pub-type="epub">1664-3224</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fimmu.2017.00815</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Immunology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title><italic>Leishmania infantum</italic> Parasites Subvert the Host Inflammatory Response through the Adenosine A2<sub>A</sub> Receptor to Promote the Establishment of Infection</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Lima</surname> <given-names>Mikhael H. F.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/441339"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Sacramento</surname> <given-names>Lais A.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/365819"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Quirino</surname> <given-names>Gustavo F. S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/84838"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Ferreira</surname> <given-names>Marcela D.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/358555"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Benevides</surname> <given-names>Luciana</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/365802"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Santana</surname> <given-names>Alynne K. M.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/435090"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Cunha</surname> <given-names>Fernando Q.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff3"><sup>3</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/321443"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Almeida</surname> <given-names>Roque P.</given-names></name>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/457026"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Silva</surname> <given-names>Jo&#x000E3;o S.</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<uri xlink:href="http://frontiersin.org/people/u/314181"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Carregaro</surname> <given-names>Vanessa</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor1">&#x0002A;</xref>
<uri xlink:href="http://frontiersin.org/people/u/365816"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Laboratory of Immunoparasitology, Department of Biochemistry and Immunology, School of Medicine of Ribeir&#x000E3;o Preto, University of S&#x000E3;o Paulo</institution>, <addr-line>Ribeir&#x000E3;o Preto, S&#x000E3;o Paulo</addr-line>, <country>Brazil</country></aff>
<aff id="aff2"><sup>2</sup><institution>Laboratory of Molecular Biology, Center for Biology and Health Sciences, Federal University of Sergipe</institution>, <addr-line>Aracaju, Sergipe</addr-line>, <country>Brazil</country></aff>
<aff id="aff3"><sup>3</sup><institution>Laboratory of Inflammation and Pain, Department of Pharmacology, School of Medicine of Ribeir&#x000E3;o Preto, University of S&#x000E3;o Paulo</institution>, <addr-line>Ribeir&#x000E3;o Preto, S&#x000E3;o Paulo</addr-line>, <country>Brazil</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Uwe Ritter, University of Regensburg, Germany</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Emilio Luis Malchiodi, University of Buenos Aires (UBA), Argentina; Hira Nakhasi, US Food and Drug Administration, United States</p></fn>
<corresp content-type="corresp" id="cor1">&#x0002A;Correspondence: Vanessa Carregaro, <email>vcarregaro&#x00040;usp.br</email>, <email>vcarregaro&#x00040;fmrp.usp.br</email></corresp>
<fn fn-type="other" id="fn001"><p>Specialty section: This article was submitted to Microbial Immunology, a section of the journal Frontiers in Immunology</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>20</day>
<month>07</month>
<year>2017</year>
</pub-date>
<pub-date pub-type="collection">
<year>2017</year>
</pub-date>
<volume>8</volume>
<elocation-id>815</elocation-id>
<history>
<date date-type="received">
<day>13</day>
<month>04</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>27</day>
<month>06</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x000A9; 2017 Lima, Sacramento, Quirino, Ferreira, Benevides, Santana, Cunha, Almeida, Silva and Carregaro.</copyright-statement>
<copyright-year>2017</copyright-year>
<copyright-holder>Lima, Sacramento, Quirino, Ferreira, Benevides, Santana, Cunha, Almeida, Silva and Carregaro</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Adenosine is an endogenously released purine nucleoside that signals through four widely expressed G protein-coupled receptors: A1, A2<sub>A</sub>, A2<sub>B</sub>, and A3. Of these, A<sub>2A</sub>R is recognized as mediating major adenosine anti-inflammatory activity. During cutaneous leishmaniasis, adenosine induces immunosuppression, which promotes the establishment of infection. Herein, we demonstrated that A<sub>2A</sub>R signaling is exploited by <italic>Leishmania infantum</italic> parasites, the etiologic agent that causes Visceral Leishmaniasis, to successfully colonize the vertebrate host. A<sub>2A</sub>R gene-deleted mice exhibited a well-developed cellular reaction with a strong Th1 immune response in the parasitized organs. An intense infiltration of activated neutrophils into the disease-target organs was observed in A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice. These cells were characterized by high expression of CXCR2 and CD69 on their cell surfaces and increased <italic>cxcl1</italic> expression. Interestingly, this phenotype was mediated by IFN-&#x003B3; on the basis that a neutralizing antibody specific to this cytokine prevented neutrophilic influx into parasitized organs. In evaluating the immunosuppressive effects, we identified a decreased number of CD4<sup>&#x0002B;</sup> FOXP3<sup>&#x0002B;</sup> T cells and reduced <italic>il10</italic> expression in A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> infected mice. During <italic>ex vivo</italic> cell culture, A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> splenocytes produced smaller amounts of IL-10. In conclusion, we demonstrated that the A<sub>2A</sub>R signaling pathway is detrimental to development of Th1-type adaptive immunity and that this pathway could be associated with the regulatory process. In particular, it promotes parasite surveillance.</p>
</abstract>
<kwd-group>
<kwd>visceral leishmaniasis</kwd>
<kwd>adenosine</kwd>
<kwd>immunoregulation</kwd>
<kwd>A<sub>2A</sub>R signaling</kwd>
<kwd>inflammation</kwd>
</kwd-group>
<counts>
<fig-count count="6"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="77"/>
<page-count count="12"/>
<word-count count="9056"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="introduction">
<title>Introduction</title>
<p><italic>Leishmania</italic> parasites are the etiological agent of a wide spectrum of diseases in mammals and other vertebrates (<xref ref-type="bibr" rid="B1">1</xref>). Among this complex of diseases, Visceral Leishmaniasis (VL), which is caused by <italic>L. donovani</italic> or <italic>L. infantum</italic>, is one of the most severe clinical manifestations of infection with <italic>Leishmania</italic> parasites and is a major cause of human mortality and morbidity worldwide (<xref ref-type="bibr" rid="B2">2</xref>&#x02013;<xref ref-type="bibr" rid="B4">4</xref>).</p>
<p>The most effective mechanisms for protection against <italic>Leishmania</italic> involve the generation of CD4<sup>&#x0002B;</sup> Th1&#x02009;cells. These cells secrete IFN-&#x003B3;, which activates phagocytic cells, such as neutrophils, macrophages, and dendritic cells (DCs), to release reactive oxygen species (ROS) and nitric oxide (NO). These mediators lead to the death of the parasites (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). IL-17, which is produced by the Th17 subset, can act synergistically with IFN-&#x003B3; to increase the NO production and the anti-Leishmanial ability of the infected macrophages (<xref ref-type="bibr" rid="B7">7</xref>). Despite having several microbicidal activities to control parasite growth, the host defense can be subverted by the <italic>Leishmania</italic> parasite to provide a typical microenvironment for initiation and maintenance of successful infection. The mechanisms that are altered could involve those mediated by cellular response [i.e., Th2 subset, regulatory T cells (Tregs)], anti-inflammatory cytokines (IL-10, TGF-&#x003B2;), and some metabolites that have a high capacity to inhibit leukocyte migration and activation (<xref ref-type="bibr" rid="B8">8</xref>), including arachidonic acid metabolites (Prostaglandins E and J series) and adenosine (<xref ref-type="bibr" rid="B9">9</xref>, <xref ref-type="bibr" rid="B10">10</xref>).</p>
<p>Adenosine is a potent immunomodulatory biomolecule that is produced by the ecto-enzymes CD39 (nucleoside triphosphate dephosphorylase) and CD73 (ecto-5&#x02032;-nucleotidase), which are highly expressed by several cell types including leukocytes during stress, injury, and infection (<xref ref-type="bibr" rid="B11">11</xref>). Under these circumstances, extracellular ATP is hydrolyzed by CD39, which converts ATP or ADP into AMP, and subsequently CD73 rapidly dephosphorylates AMP to adenosine (ADO) (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B13">13</xref>). After being generated, adenosine modulates the immunological responses through the activation of four G-protein-coupled transmembrane receptors (GPCRs) that can either stimulate (Gs) or inhibit (Gi) adenylyl cyclase, which catalyzes the formation of cyclic AMP (cAMP), which inhibits immune cell function. The adenosine A1 and A3 receptors are high- and low-affinity receptors for adenosine, respectively, and both are coupled to Gi, which decreases the generation of cAMP. By contrast, the high-affinity A2<sub>A</sub> and low-affinity A2<sub>B</sub> receptors activate adenylyl cyclase, thereby increasing the intracellular levels of cAMP (<xref ref-type="bibr" rid="B14">14</xref>, <xref ref-type="bibr" rid="B15">15</xref>). Thus, A<sub>2A</sub>R and A<sub>2B</sub>R regulate multiple physiologic responses, including the anti-inflammatory and immunosuppressive effects of ADO. Genetic ablation or pharmacologic inhibition of A<sub>2A</sub>R or A<sub>2B</sub>R leads to excessive immune responses (<xref ref-type="bibr" rid="B16">16</xref>, <xref ref-type="bibr" rid="B17">17</xref>).</p>
<p>The A<sub>2A</sub>R is widely distributed on the surfaces of several types of leukocytes, including neutrophils, monocytes, macrophages, DCs, T cells, and natural killer (NK) cells (<xref ref-type="bibr" rid="B18">18</xref>). Among its activities, A<sub>2A</sub>R activation blocks the classical macrophage activation by inhibiting its microbicidal machinery (<xref ref-type="bibr" rid="B19">19</xref>), attenuating phagocytosis (<xref ref-type="bibr" rid="B20">20</xref>), and blocking the production of ROS by phagocytes (<xref ref-type="bibr" rid="B21">21</xref>, <xref ref-type="bibr" rid="B22">22</xref>). Moreover, A<sub>2A</sub>R signaling reduces the leukocyte recruitment to inflammatory foci (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>), induces T cell anergy (<xref ref-type="bibr" rid="B25">25</xref>, <xref ref-type="bibr" rid="B26">26</xref>), and promotes both regulatory T cell generation and suppressive functions (<xref ref-type="bibr" rid="B27">27</xref>, <xref ref-type="bibr" rid="B28">28</xref>). Furthermore, adenosine, acting through A<sub>2A</sub>R signaling, inhibits the DC ability to present antigen, thus leading to suppression of the Th17 subset dependent on IL-10 production (<xref ref-type="bibr" rid="B29">29</xref>).</p>
<p>In addition to these effects on the host cells, there is increasing evidence that microorganisms escape from the control of the immune system due to the synthesis of adenosine at the site of infection, which favors invasion and dissemination of infectious agents. Several microorganisms, including protozoa (belonging to the genus <italic>Trypanosoma, Toxoplasma, Trichomonas, Giardia</italic>) (<xref ref-type="bibr" rid="B30">30</xref>&#x02013;<xref ref-type="bibr" rid="B36">36</xref>), fungi (<italic>Candida parapsilosis</italic>) (<xref ref-type="bibr" rid="B37">37</xref>), bacteria (<xref ref-type="bibr" rid="B38">38</xref>&#x02013;<xref ref-type="bibr" rid="B40">40</xref>), and worms (<italic>Schistosoma mansoni</italic> and <italic>S. japonicum</italic>) (<xref ref-type="bibr" rid="B41">41</xref>, <xref ref-type="bibr" rid="B42">42</xref>) express CD39&#x02013;CD73-like machinery that may aid pathogen colonization and dissemination. <italic>Leishmania</italic> parasites can also take advantage of ectonucleotidases expressed on their membrane surfaces to escape from immunological surveillance (<xref ref-type="bibr" rid="B32">32</xref>, <xref ref-type="bibr" rid="B43">43</xref>&#x02013;<xref ref-type="bibr" rid="B45">45</xref>). In cutaneous leishmaniasis, we previously demonstrated that ADO and AMP present in saliva of <italic>Phlebotomus papatasi, a Leishmania vector</italic>, mediate the immunosuppressive effects. ADO and AMP act through A<sub>2A</sub>R to induce a tolerogenic profile on dendritic cells by sequential production of PGE<sub>2</sub> and IL-10. Both mediators could also act in a paracrine manner to induce Tregs from Teff populations, thus leading to suppression of the immune response and parasite spreading (<xref ref-type="bibr" rid="B46">46</xref>).</p>
<p>An interesting issue is that, in general, the visceral <italic>Leishmania</italic> species are less inflammatory than the cutaneous <italic>Leishmania</italic> species (<xref ref-type="bibr" rid="B47">47</xref>). Intriguingly, the viscerotropic <italic>Leishmania</italic> species (<italic>L. infantum</italic> and <italic>L. donovani</italic>) demonstrate higher 3&#x02032;-nucleotidase activity than the cutaneous species (<xref ref-type="bibr" rid="B48">48</xref>). Furthermore, patients with VL have high levels of adenosine in their serum, which is related to the ectonucleotidase activities and disease progression (<xref ref-type="bibr" rid="B49">49</xref>). In addition, under inflammatory conditions, A<sub>2B</sub>R is highly expressed in the monocytes from VL patients (<xref ref-type="bibr" rid="B50">50</xref>), which suggests that during this disease, the <italic>Leishmania</italic> parasites may use the adenosinergic signaling pathway to evade host immune response, which contributes to their silent growth and survival inside cells. However, the role of high-affinity A<sub>2A</sub>R receptor on VL remains to be elucidated. In this context, in this study, we demonstrate that the <italic>L. infantum</italic> parasite benefits from purinergic signaling mediated by the A<sub>2A</sub>R pathway in the host cells to subvert the immune response. Mechanistically, A<sub>2A</sub>R signaling negatively regulates the migration and activation of neutrophils that are induced by Th1&#x02009;cells, thus allowing the establishment of the infection caused by parasite in the susceptible BALB/c mice.</p>
</sec>
<sec id="S2" sec-type="materials|methods">
<title>Materials and Methods</title>
<sec id="S2-1">
<title>Mice</title>
<p>Female BALB/c (wild type; WT) and BALB/c-A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup>) mice that weighed between 18 and 22&#x02009;g were housed in the animal facility of the Department of Biochemistry and Immunology, School of Medicine of Ribeir&#x000E3;o Preto, University of S&#x000E3;o Paulo (Brazil) in temperature-controlled rooms (22&#x02013;25&#x000B0;C) and received water and food <italic>ad libitum</italic>. All experiments were conducted in accordance with the National Institutes of Health (NIH) guidelines on the welfare of experimental animals and with the approval of the Ethics Committee of the School of Medicine of Ribeir&#x000E3;o Preto (No 196/2011).</p>
</sec>
<sec id="S2-2">
<title>Parasites, Infection, and Parasites Load Estimation</title>
<p>Isolate HU-UFS14 of <italic>L. infantum</italic> was cultured in Schneider medium supplemented with 20% heat-inactivated fetal bovine serum (Gibco<sup>&#x000AE;</sup>, Life Technologies, Carlsbad, CA, USA), 5% penicillin and streptomycin (all from Sigma-Aldrich, St. Louis, MO, USA), and 2% human male urine. The mice were intravenously infected with 10<sup>7</sup> of the promastigote form of <italic>L. infantum</italic> parasites in the stationary growth phase. The hepatic and splenic parasite burdens were determined using a quantitative limiting dilution assay (<xref ref-type="bibr" rid="B51">51</xref>, <xref ref-type="bibr" rid="B52">52</xref>).</p>
</sec>
<sec id="S2-3">
<title>Histopathological and Immunohistochemical Analyses</title>
<p>The mice were euthanized 0, 4, and 6&#x02009;weeks after infection, and their livers were removed. The tissues were fixed in formalin, dehydrated in graded ethanol, and embedded in paraffin. Serial sections (5&#x02009;&#x000B5;m) were cut and mounted on glass slides that had been precoated with 0.1% poly-<sc>l</sc>-lysine (Sigma-Aldrich). Histological assessment was performed after routine hematoxylin-eosin staining. The extent of granuloma formation was analyzed in 50 fields per animal, being classified as: none granuloma, which is characterized by some parasitized cells but in the absence of inflammatory cells surrounding them; developing granuloma, which is characterized as parasitized cells surrounded by some inflammatory leukocytes; mature granuloma, in which the fused parasitized cells are surrounded by a mantle of mononuclear and polymorphonuclear cells; and empty granuloma, when no parasites could be seen inside the areas of the granulomatous reaction (<xref ref-type="bibr" rid="B53">53</xref>). For immunohistochemical reactions, the paraffin was removed from the tissues, and antigenic recovery was performed by heating in citrate buffer (pH 6.0), for 30&#x02009;min at 37&#x000B0;C. Endogenous peroxidase was blocked using 3% H<sub>2</sub>O<sub>2</sub>, the cells were permeabilized with 0.5% Triton, and non-specific reactions were blocked with 1% bovine serum albumin. The sections were incubated overnight with rat anti-mouse Ly6G (clone 1A8) (Biolegend, San Diego, CA, USA), or isotype control antibodies (Abcam, Cambridge, MA, USA), followed by incubation with a biotinylated secondary antibody and avidin-biotin complex (Vector Laboratories, ON, Canada). The reaction was detected with diaminobenzidine, and the sections were counterstained with Mayer&#x02019;s hematoxylin. For the intracellular staining of iNOS, the liver sections were permeabilized with 0.01% saponin and incubated with rabbit anti-mouse iNOS (clone sc-649) (Santa Cruz Biotechnology, Dallas, TX, USA). Afterward, the sections were incubated with an avidin-biotin-peroxidase complex (Vector Laboratories, ON, Canada), and the color was developed using 3,3&#x02032;-diaminobenzidine (Vector Laboratories). The slides were counterstained with Mayer&#x02019;s hematoxylin. The areas positive for iNOS staining in the hepatic tissue were quantified using IHC Toolbox Software ImageJ (NIH, MacBiophotonics, Boston, MA, USA). The isotype control from iNOS and LY6G staining by immunohistochemistry is showed as Figure S1 in Supplementary Material.</p>
</sec>
<sec id="S2-4">
<title>Evaluation of Inflammatory Infiltration in the Liver</title>
<p>The liver leukocytes were recovered using Ficoll-Paque PLUS gradient centrifugation. After processing, the viability was assessed using Trypan blue exclusion and the cell concentration was determined. For cytokine staining, the cells were preincubated with 20&#x02009;ng/ml of PMA, 500&#x02009;ng/ml of ionomycin, and Golgi Plug for 6&#x02009;h; permeabilized using a Cytofix/Cytoperm kit according to the manufacturer&#x02019;s instructions; and stained with &#x003B1;-IL-17A conjugated with Alexa700 and &#x003B1;-IFN-&#x003B3; conjugated with APC-CY7. For FoxP3 labeling, the Foxp3 Staining Kit was used according to the manufacturer&#x02019;s recommendations. For each sample, data from a minimum of 200,000 cells were acquired using a FACSCanto II flow cytometer and analyzed using FlowJo software (Tree Star, OR, USA).</p>
</sec>
<sec id="S2-5">
<title>Splenic Cell Culture and Cytokine Measurement</title>
<p>Single-cell suspensions from the spleens of the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> or WT mice at various time points of infection were prepared aseptically, diluted to a concentration of 2&#x02009;&#x000D7;&#x02009;10<sup>6</sup> cells/ml, and dispensed into 48-well plates in a total volume of 500&#x02009;&#x000B5;l of complete RPMI-1640 medium (1&#x02009;&#x000D7;&#x02009;10<sup>6</sup> cells/well; Gibco) with or without soluble <italic>Leishmania</italic> antigen (SLA) (5&#x02009;&#x000B5;g/ml). The cell culture supernatants were harvested after 72&#x02009;h of culture at 37&#x000B0;C in 5% CO<sub>2</sub>, and levels of IFN-&#x003B3; and IL-10 were determined using ELISA with commercial kits (BD Biosciences and R&#x00026;D Systems, Minneapolis, MN, USA).</p>
<p>For leukocyte identification, the inflammatory cells were gated based on their characteristic size (FSC) and granularity (SSC), and the T lymphocytes (CD4<sup>&#x0002B;</sup> CD3<sup>&#x0002B;</sup>) and neutrophils (Ly6G<sup>high</sup>MHCII<sup>&#x02212;</sup>) were individually identified. For intracellular staining, the cells were previously cultured with PMA (50&#x02009;ng/ml) and ionomycin for 4&#x02009;h, permeabilized with a Cytofix/Cytoperm kit (BD Biosciences) according to the manufacturer&#x02019;s guide and stained with APC-Cy7-labeled &#x003B1;-IFN-&#x003B3; or Alexa700-labeled &#x003B1;-IL-17 and surface-stained with FITC-labeled &#x003B1;-CD3 and PerCP-labeled &#x003B1;-CD4. For the neutrophil activation analysis, the cells were stained with antibodies to &#x003B1;-Ly6G, &#x003B1;-CD11b, &#x003B1;-CXCR2, and &#x003B1;-CD69 with APC, FITC, PERCP, and PEcy7, respectively. Foxp3 labeling were carried out using the Mouse Foxp3 Buffer Set (BD Pharmigen&#x02122;) and Foxp3 (Alexa 647) antibodies. The isotype controls used were rat IgG2b and rat IgG2a. All antibodies were from BD Biosciences or eBiosciences (San Diego, CA, USA). The cell acquisition was performed using a FACSort flow cytometer. The data were plotted and analyzed using the FlowJo software (Tree Star, Ashland, OR, USA). Gating strategies were determined represented the leukocyte counts were determined by measuring the relative proportions of the leukocyte subpopulations that stained with the specific antibodies in a total of 200,000 acquired events relative to the total leukocyte numbers obtained in a Neubauer chamber. The Strategy gate for identification of inflammatory leukocytes during <italic>L. infantum</italic> infection was showed as Figure S2 in Supplementary Material.</p>
</sec>
<sec id="S2-6">
<title>IFN-&#x003B3; Depletion <italic>In Vivo</italic></title>
<p>WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice were treated (i.p.) with the monoclonal antibody anti-mouse IFN-&#x003B3; clone XMG1.2 (BioXCell, West Lebanon, New Hampshire, EUA). Briefly, the mice were given 20&#x02009;&#x000B5;g of antibody 1&#x02009;day before and a second dose 24&#x02009;h after the infection. From the fourth week post infection, the animals were treated with 10&#x02009;&#x000B5;g every 3&#x02009;days for 2&#x02009;weeks thereafter. The control group was treated with an irrelevant mab IgG following the same schedule.</p>
</sec>
<sec id="S2-7">
<title>T Cell Proliferation, T Cell Isolation, and Th1 Differentiation</title>
<p>Spleens from na&#x000EF;ve WT or A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice and the cells were filtered through a cell strainer, centrifuged at 500&#x02009;&#x000D7;&#x02009;<italic>g</italic> at 4&#x000B0;C for 10&#x02009;min, and resuspended in RPMI-1640 medium at 2.5&#x02009;&#x000D7;&#x02009;10<sup>6</sup> cells/ml. The cells were stained with CSFE and stimulated with plate-bound &#x003B1;-CD3 mAb (2&#x02009;&#x000B5;g/ml) and &#x003B1;-CD28 (1&#x02009;&#x000B5;g/ml), or medium for 4&#x02009;days in a total volume of 500&#x02009;&#x000B5;l per condition. The lymph proliferation was determined by CFSE staining by flow cytometry assay. For Th1 differentiation, CD4<sup>&#x0002B;</sup> T cells were isolated from spleen cell suspensions of na&#x000EF;ve WT or A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> and stimulated with plate-bound &#x003B1;-CD3 (2&#x02009;&#x000B5;g/ml), &#x003B1;-CD28 (1&#x02009;&#x000B5;g/ml) (both from BioXCell) for 4&#x02009;days in RPMI-1640 medium supplemented with 5% FBS (Gibco), 100&#x02009;U/ml penicillin/100&#x02009;&#x000B5;g/ml streptomycin, 1&#x02009;mM sodium pyruvate, non-essential amino acids, <sc>l</sc>-glutamine and 50&#x02009;&#x000B5;M 2-mercaptoethanol in the presence of recombinant cytokines. For Th1, differentiation was included IL-12 (5&#x02009;ng/ml) plus anti-IL-4 (10&#x02009;&#x000B5;g/ml) in addition to IL-2 (25&#x02009;U/ml). All recombinant cytokines were obtained from RD and neutralizing antibodies were obtained from BioXCell. After 4&#x02009;days of culture, differentiated cells were reestimulated with PMA (50&#x02009;ng/ml), ionomycin (500&#x02009;ng/ml) (Sigma-Aldrich), and brefeldin A for 4&#x02009;h.</p>
</sec>
<sec id="S2-8">
<title>Quantitative Polymerase Chain Reaction (qPCR)</title>
<p>The total RNA was extracted from the tissues using the TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and the SV Total RNA Isolation System Kit (Promega, Madison, WI, USA) according to the manufacturer&#x02019;s instructions. Complementary DNA was synthesized using Transcriptase Reverse SuperScript III (Invitrogen). SYBR Green Mix-based quantitative PCR assays were performed using the StepOnePlus Real-time PCR System (Applied Biosystems, Singapore, Malaysia). The mean threshold cycle (<italic>C</italic><sub>t</sub>) values of duplicate measurements were used to calculate the expression of the target gene, which was normalized to the housekeeping genes <italic>Actb, B2m</italic> and <italic>Gapdh</italic> using the <inline-formula><mml:math id="M1"><mml:mrow><mml:msup><mml:mn>2</mml:mn><mml:mrow><mml:mo>&#x02212;</mml:mo><mml:mi mathvariant="normal">&#x00394;&#x00394;</mml:mi><mml:msub><mml:mi>C</mml:mi><mml:mtext>t</mml:mtext></mml:msub></mml:mrow></mml:msup></mml:mrow></mml:math></inline-formula> formula. The standard PCR conditions were as follows: 50&#x000B0;C for 2&#x02009;min, 95&#x000B0;C for 2&#x02009;min and 40 cycles of 15&#x02009;s at 95&#x000B0;C, 30&#x02009;s at 58&#x000B0;C and 30&#x02009;s at 72&#x000B0;C, followed by a standard denaturation curve.</p>
</sec>
<sec id="S2-9">
<title>Statistical Analysis</title>
<p>The data are expressed as the means&#x02009;&#x000B1;&#x02009;SD and are representative of two to four independent experiments. The results from individual experiments were not combined because they were analyzed individually. The means of the different groups were compared by ANOVA followed by Tukey&#x02019;s honest significant difference test. Comparisons between two groups were performed using Student&#x02019;s <italic>t</italic>-test. The analyses were performed using Prism 5.0 software (GraphPad). Statistical significance was set at <italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05.</p>
</sec>
</sec>
<sec id="S3">
<title>Results</title>
<sec id="S3-1">
<title>A<sub>2A</sub>R Contributes to Susceptibility during <italic>In Vivo L. infantum</italic> Infection</title>
<p>To investigate the relevance of A<sub>2A</sub>R in the course of <italic>L. infantum</italic> infection, A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice and control littermates were intravenously infected with 10<sup>7</sup> promastigote forms of <italic>L. infantum</italic>, and the parasite loads in the spleens and livers were quantified at various times after the infection. Strikingly, and in contrast to the WT counterparts, the spleens of the mice lacking A<sub>2A</sub>R harbored reduced parasite loads in both periods (Figure <xref ref-type="fig" rid="F1">1</xref>A); whereas, in the livers, fewer parasites were observed only at the sixth wpi (Figure <xref ref-type="fig" rid="F1">1</xref>B). This result suggested that A<sub>2A</sub>R participates in the establishment of visceral <italic>Leishmania</italic> infection. Surprisingly, the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice exhibited increased weights of both spleen and liver compared to the WT mice (Figures <xref ref-type="fig" rid="F1">1</xref>C,D), which may be consequence of an inflammatory reaction.</p>
<fig id="F1" position="float">
<label>Figure 1</label>
<caption><p>A<sub>2A</sub>R signaling confers the susceptibility to <italic>Leishmania infantum</italic> infection. BALB/c (<italic>n</italic>&#x02009;&#x0003D;&#x02009;5) and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice (<italic>n</italic>&#x02009;&#x0003D;&#x02009;5) (white bars and black bars, respectively) were infected with 1&#x02009;&#x000D7;&#x02009;10<sup>7</sup> <italic>L. infantum</italic> promastigotes (HU-UFS 14) in stationary growth phase by the intravenous route (i.v.). The parasite burdens (Log10 scale) in the spleens <bold>(A)</bold> and livers <bold>(B)</bold> during the fourth and sixth weeks post infection (wpi) are shown. The spleen <bold>(C)</bold> and liver <bold>(D)</bold> weights (mg of tissue) from the non-infected (n.i.) and infected WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> groups at the fourth and sixth weeks post infection are shown. The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD, &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the infected WT group, <sup>&#x00023;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the non-infected WT group, and <sup>&#x00026;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the uninfected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> group.</p></caption>
<graphic xlink:href="fimmu-08-00815-g001.tif"/>
</fig>
<p>One feature of VL is the formation of granulomas in an attempt to control the spreading of parasite (<xref ref-type="bibr" rid="B2">2</xref>). The granulomas can be pathologically classified as: no granuloma reaction, developing granulomas, mature granulomas, and empty granulomas (<xref ref-type="bibr" rid="B53">53</xref>). Histopathological analysis demonstrated that the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice exhibited larger areas with well-formed granulomas at sixth wpi than those observed in the WT mice. These areas included mature granulomas (Figure <xref ref-type="fig" rid="F2">2</xref>C) and empty granulomatous reactions (Figure <xref ref-type="fig" rid="F2">2</xref>D). These results were consistent with the lower parasite numbers detected in the livers (Figure <xref ref-type="fig" rid="F1">1</xref>B) and dearth areas with none granuloma reaction (Figure <xref ref-type="fig" rid="F2">2</xref>A). Moreover, we could not detect any difference with respect to the developing granuloma reactions during the fourth and sixth wpi between the WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice (Figure <xref ref-type="fig" rid="F2">2</xref>B). These data demonstrated that activation of A<sub>2A</sub>R results in the failure of BALB/c mice to control the <italic>L. infantum</italic> infection possibly due to the generation of a weaker cellular immune response.</p>
<fig id="F2" position="float">
<label>Figure 2</label>
<caption><p>A<sub>2A</sub>R disturbs the granuloma reaction during <italic>Leishmania infantum</italic> infection. WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice at fourth and sixth weeks post infection were scored for the extent of granuloma formation and classified as: no granuloma <bold>(A)</bold>, developing granuloma <bold>(B)</bold>, mature granuloma <bold>(C)</bold> and empty granuloma <bold>(D)</bold>. The data are expressed as the number of granulomas per 50 high-power fields (magnification 100&#x000D7;). The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05. All data are representative of at least three independent experiments.</p></caption>
<graphic xlink:href="fimmu-08-00815-g002.tif"/>
</fig>
</sec>
<sec id="S3-2">
<title>A<sub>2A</sub>R Inhibits the Th1 Response during <italic>L. infantum</italic> Infection</title>
<p>Because the development of IFN-&#x003B3;-producing CD4<sup>&#x0002B;</sup> T helper cells is crucial for the control of parasite replication in the target organs of VL, we investigated whether this response could be affected in A<sub>2A</sub>R-dependent manner. The <italic>Ifng</italic> gene expression was upregulated in the livers (Figure <xref ref-type="fig" rid="F3">3</xref>B), but it not altered into spleen (Figure <xref ref-type="fig" rid="F3">3</xref>A), of the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice at the sixth wpi compared to the control littermates. In terms of protein, IFN-&#x003B3; production was measured in response to restimulation of the spleen cells from A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> or WT mice with the SLA. Stimulation of the cells from the WT mice with SLA induced the release of significant amounts of IFN-&#x003B3; into culture supernatant compared with WT control (medium-without SLA) Figure <xref ref-type="fig" rid="F3">3</xref>C. However, the supernatants of the spleen cells from the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice contained higher levels of this cytokine by in comparison with supernatants stimulated WT cells. This profile was weakly observed at the fourth wpi, but it was pronounced at the sixth wpi. Moreover, there is a significant difference in the amounts of IFN-&#x003B3; into culture supernatants from antigen-stimulated A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> compared with respective A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> control (medium- without SLA). The <italic>Leishmania</italic> antigen had minimal effects on the basal IFN-&#x003B3; release in either strain of non-infected mice.</p>
<fig id="F3" position="float">
<label>Figure 3</label>
<caption><p>A<sub>2A</sub>R regulates the establishment of the Th1 immune response in the course of <italic>Leishmania infantum</italic> infection. Fragments from the spleens <bold>(A)</bold> and livers <bold>(B)</bold> from the WT (white bars, <italic>n</italic>&#x02009;&#x0003D;&#x02009;5) and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (black bars, <italic>n</italic>&#x02009;&#x0003D;&#x02009;5) mice were subjected to quantitative polymerase chain reaction (qPCR) analysis to evaluate the expression of <italic>ifng</italic> mRNA. The IFN-&#x003B3; produced by the splenic cells of the non-infected and infected WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice in the presence or absence of <italic>L. infantum</italic> antigens is shown <bold>(C)</bold>. The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD, &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 for the comparison with <italic>Leishmania</italic> antigen or medium stimuli. The dot plots represent the frequency of CD4<sup>&#x0002B;</sup> IFN-&#x003B3;<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup> cells <bold>(D)</bold>. The frequencies <bold>(E)</bold> and absolute numbers <bold>(F)</bold> of CD4<sup>&#x0002B;</sup> IFN-&#x003B3;<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup> cells that were present in the spleens of the non-infected (n.i.) and infected mice at fourth and sixth weeks of infection are shown. Representative photos of the NOS2 staining by immunohistochemistry in the hepatic tissues from the WT (<italic>n</italic>&#x02009;&#x0003D;&#x02009;5) and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (<italic>n</italic>&#x02009;&#x0003D;&#x02009;5) mice at the sixth wpi <bold>(G)</bold>. The photomicrographs are shown at 20X magnification. The positive percentage of NOS2-stained area at the sixth wpi was quantified using ImageJ<sup>&#x000AE;</sup> software analysis. The mRNA for <italic>nos2</italic> expression in spleen was quantified using qPCR <bold>(H)</bold>. The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD, <sup>&#x00023;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the non-infected WT, <sup>&#x00026;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the non-infected A<sub>2A</sub>R group, and &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 for the comparison of the infected WT group.</p></caption>
<graphic xlink:href="fimmu-08-00815-g003.tif"/>
</fig>
<p>By flow cytometry, we observed that infection with <italic>L. infantum</italic> promoted a significant induction of IFN-&#x003B3;-producing CD4<sup>&#x0002B;</sup> T cells in both BALB/c and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice compared to their counterparts in terms of both percentages (Figures <xref ref-type="fig" rid="F3">3</xref>D,E) and total number of cells (Figure <xref ref-type="fig" rid="F3">3</xref>F). However, it must be noted that the previously mentioned Th1 profile enhancement was heightened in A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice. Moreover, the infection promoted the expansion of the CD4<sup>&#x0002B;</sup> IL-17<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup> cells, but such population was not affected in the absence of the receptor. There were no differences between the WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice in the frequencies and absolute numbers of the CD4<sup>&#x0002B;</sup> IL-17<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup> (Figures S3A,B in Supplementary Material). We also could not see any difference in the frequency and number of IL-17 production by other CD3<sup>&#x0002B;</sup> population, herein characterized as CD4<sup>&#x02212;</sup> IL-17<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup>, that could be CD8<sup>&#x0002B;</sup> T, NK<sup>&#x0002B;</sup> T, or &#x003B3;&#x003B4;<sup>&#x0002B;</sup> T cells between WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (Figures S3A,C in Supplementary Material).</p>
<p>A considerable body of evidence has shown that the Th1 subset produces IFN-&#x003B3;, which in turn induces expression of iNOS (NOS2) in infected phagocytes, which generates NO (<xref ref-type="bibr" rid="B54">54</xref>). The resulting production of NO by iNOS represents an important tool to kill <italic>Leishmania</italic> sp parasites (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). By qPCR, we detected greater <italic>Nos2</italic> mRNA expression in the spleens of the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice than in the WT group at both the fourth and sixth weeks post infection (Figure <xref ref-type="fig" rid="F3">3</xref>H). Likewise, greater areas positive for iNOS staining were observed in the livers of the knockout mice at sixth week post infection than in the WT group (Figure <xref ref-type="fig" rid="F3">3</xref>G). These results suggested that A<sub>2A</sub>R activation downregulated the Th1 responses which could favor the parasite spreading.</p>
</sec>
<sec id="S3-3">
<title>A<sub>2A</sub>R Regulates both Neutrophil Recruitment and Activation through an IFN-&#x003B3;-Dependent Mechanism</title>
<p>Neutrophils are recruited to <italic>Leishmania</italic> inoculation foci (<xref ref-type="bibr" rid="B55">55</xref>) and participate in the restriction of the parasites during VL (<xref ref-type="bibr" rid="B56">56</xref>, <xref ref-type="bibr" rid="B57">57</xref>). Because neutrophils both produce and respond to adenosine (<xref ref-type="bibr" rid="B58">58</xref>), we addressed whether A<sub>2A</sub>R signaling affected the neutrophilic inflammation in target organs of the disease.</p>
<p>On the basis of the size (FSC) and granularity (SSC) characteristics, we found a higher frequency of leukocytes with a high side-scatter height, a classical gate for granulocytes, in the infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice compared to the infected WT mice (Figure <xref ref-type="fig" rid="F4">4</xref>A). Using specific antibodies to identify the neutrophils, we observed differences in absolute numbers of Ly6G<sup>&#x0002B;</sup> CD11b<sup>&#x0002B;</sup> cells (neutrophils markers) at fourth wpi and the most notable difference was that the neutrophilic influx observed at sixth wpi that was greater both in percentage (Figures <xref ref-type="fig" rid="F4">4</xref>B,C) and total number (Figure <xref ref-type="fig" rid="F4">4</xref>D) of cells in the infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice than in the littermate controls. Interestingly, the strong neutrophilic influx in the absence of A<sub>2A</sub>R was associated with the increased expression of <italic>cxcl1</italic>, which codes for an important neutrophil chemotactic mediator, by the spleen cells (Figure <xref ref-type="fig" rid="F4">4</xref>E). Subsequently, we used flow cytometry to examine the surface molecules expressed on surface of CD11b<sup>&#x0002B;</sup> Ly6G<sup>&#x0002B;</sup> cells to determine whether differences in expression of CXCR2 or CD69, relative to neutrophil migration (<xref ref-type="bibr" rid="B59">59</xref>&#x02013;<xref ref-type="bibr" rid="B61">61</xref>) and activation (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>), respectively, could account for the strong inflammatory process encountered in the tissues of the infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice. Consistent with these observations, the neutrophils from the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice exhibited an enhanced expression of CXCR2, the CXCL1 receptor (Figure <xref ref-type="fig" rid="F4">4</xref>F; Figure S4 in Supplementary Material). Among the neutrophil activation marker, we observed that the integrated median fluorescence intensity (iMFI) for CD69 from the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> neutrophils was significantly higher than the iMFI for these markers on the WT neutrophils (Figure <xref ref-type="fig" rid="F4">4</xref>G; Figure S4 in Supplementary Material). Likewise, consistent with the spleen results, the liver sections from the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice showed a marked increase in the stained neutrophils that infiltrated into the hepatic granulomas (Figure <xref ref-type="fig" rid="F4">4</xref>J). By flow cytometry, higher neutrophils were detected into liver of A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice (Figures <xref ref-type="fig" rid="F4">4</xref>H,I), which suggests that both neutrophil migration and activation may be affected by the adenosine receptor during VL.</p>
<fig id="F4" position="float">
<label>Figure 4</label>
<caption><p>A<sub>2A</sub>R decreases the neutrophil recruitment to the foci of infections during <italic>Leishmania infantum</italic> infection. Granulocytes were identified according to their size (FSC) and granularity (SSC) <bold>(A)</bold> and further neutrophils were characterized as CD11b<sup>&#x0002B;</sup> Ly6G<sup>&#x0002B;</sup> cells <bold>(B)</bold> by flow cytometric analysis. The dot-plots represent the frequency <bold>(C)</bold> and the absolute number <bold>(D)</bold> of CD11b<sup>&#x0002B;</sup> LY6G<sup>&#x0002B;</sup> cells in the spleens of the non-infected (n.i.) and infected (4 wpi and 6 wpi) WT (white bars, <italic>n</italic>&#x02009;&#x0003D;&#x02009;5) and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (black bars, <italic>n</italic>&#x02009;&#x0003D;&#x02009;5) mice. <italic>Cxcl1</italic> gene expression in the spleens from non-infected (n.i.) and infected WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice (4 wpi and 6 wpi) <bold>(E)</bold>. Expression of CXCR2 <bold>(F)</bold> and CD69 <bold>(G)</bold> (integrated median fluorescence intensity) on surface of CD11b<sup>&#x0002B;</sup> LY6G<sup>&#x0002B;</sup> cells at 6 wpi in the spleens of the WT (white bars, <italic>n</italic>&#x02009;&#x0003D;&#x02009;5) and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (black bars, <italic>n</italic>&#x02009;&#x0003D;&#x02009;5) animals. The percentages <bold>(H)</bold> and absolute numbers <bold>(I)</bold> of CD11b<sup>&#x0002B;</sup> LY6G<sup>&#x0002B;</sup> cells in the livers of WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice at sixth wpi determined by flow cytometry are shown. Representative photos of Ly6G staining by immunohistochemistry in the hepatic tissue at the sixth wpi <bold>(J)</bold> are shown. The photomicrographs are shown at 100X magnification. The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD, <sup>&#x00023;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the non-infected WT group, <sup>&#x00026;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the non-infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> group, and &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the infected WT group.</p></caption>
<graphic xlink:href="fimmu-08-00815-g004.tif"/>
</fig>
<p>It has been determined that IFN-&#x003B3; directly modulates neutrophil behavior to favor the expression of molecules involved with cell adhesion, migration, activation, and killing activity (<xref ref-type="bibr" rid="B64">64</xref>). To assess whether IFN-&#x003B3; could be responsible for the neutrophilic influx into the target organs of the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice, we blocked IFN-&#x003B3; using a specific antibody in the infected mice. The treatment with the &#x003B1;-IFN-&#x003B3; antibody abrogated the neutrophilic inflammation, as observed by the reduction of percentage (Figures <xref ref-type="fig" rid="F5">5</xref>A,B) and total number (Figure <xref ref-type="fig" rid="F5">5</xref>C) of CD11b<sup>&#x0002B;</sup> LY6G<sup>&#x0002B;</sup> cells in the spleens of the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice. In addition, a smaller surface expression of CXCR2 (Figure <xref ref-type="fig" rid="F5">5</xref>D) and CD69 (Figure <xref ref-type="fig" rid="F5">5</xref>E) was observed in the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice treated with &#x003B1;-IFN-&#x003B3; than with respective group treated with &#x003B1;-IgG. Interestingly, none of these parameters differed between the WT mice that were treated with &#x003B1;-IFN-&#x003B3; or anti-IgG control. Together, these data suggested that A<sub>2A</sub>R may modulate the Th1 subset that is capable of inducing neutrophilic inflammation and controlling the parasite spreading into tissue.</p>
<fig id="F5" position="float">
<label>Figure 5</label>
<caption><p>A<sub>2A</sub>R regulates the neutrophil activation and recruitment into the spleen in an IFN-&#x003B3;-dependent fashion. The dot plots represent the frequency of CD11b<sup>&#x0002B;</sup> Ly6G<sup>&#x0002B;</sup> cells gated on granulocytes <bold>(A)</bold>. The frequencies <bold>(B)</bold> and absolute numbers <bold>(C)</bold> of splenic CD11b<sup>&#x0002B;</sup> Ly6G<sup>&#x0002B;</sup> cells at the sixth wpi in the WT (white bars) and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> (black bars) mice that were treated with a control antibody (&#x003B1;-IgG) or interferon-&#x003B3; neutralizing antibodies (&#x003B1;-IFN&#x003B3;) (<italic>n</italic>&#x02009;&#x0003D;&#x02009;6 mice per group). The medians of the integrated median fluorescence intensity of CXCR2 <bold>(D)</bold> and CD69 <bold>(E)</bold> gated on CD11b<sup>&#x0002B;</sup> Ly6G<sup>&#x0002B;</sup> cells from the non-treated infected mice or those treated with &#x003B1;-IFN&#x003B3; at the sixth wpi are shown. The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD, <sup>&#x00023;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the &#x003B1;-IgG-treated WT mice, <sup>&#x00026;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the &#x003B1;-IgG-treated A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice, and &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the &#x003B1;-IFN-&#x003B3;-treated WT group.</p></caption>
<graphic xlink:href="fimmu-08-00815-g005.tif"/>
</fig>
</sec>
<sec id="S3-4">
<title>The Immunoregulatory Effect of A<sub>2A</sub>R Pathway Is Related to the Tregs and IL-10 Production</title>
<p>To determine the mechanism by which A<sub>2A</sub>R modulates Th1 responses during <italic>L. infantum</italic> infection, we first examined whether T cell-intrinsic A<sub>2A</sub>R is involved in either T cells proliferation or Th1 generation. CFSE-labeled CD4<sup>&#x0002B;</sup> T cells isolated from the spleens of na&#x000EF;ve WT or A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice cultured under Th0 and Th1 condition were stimulated with &#x003B1;-CD3&#x02009;&#x0002B;&#x02009;&#x003B1;-CD28 for 4&#x02009;days. The proliferation assay was analyzed by CFSE-positivity and Th1 differentiation by either intracellular stained-IFN-&#x003B3; production or T-bet mRNA expression. The frequency of CFSE-labeled CD4<sup>&#x0002B;</sup> T cells between A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> in the presence of polyclonal stimuli was similar to that in WT cells (Figures S5A,B in Supplementary Material). Moreover, the IFN-&#x003B3;-production by A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> CD4<sup>&#x0002B;</sup> T cells maintained under Th1 condition were induced in similar levels that those in WT cells (Figure S5C in Supplementary Material). There was no significant difference in T-bet mRNA expression by WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> CD4<sup>&#x0002B;</sup> T cells under Th1 polarizing condition (Figure S5D in Supplementary Material), indicating that T cell-intrinsic A<sub>2A</sub>R does not affect the either proliferation or differentiation of Th1&#x02009;cells.</p>
<p>Taking into account that A<sub>2A</sub>R signaling can restore homeostasis by promoting Tregs generation and immunosupression (<xref ref-type="bibr" rid="B27">27</xref>) and inflammatory mediators such as IFN-&#x003B3; can limit the Treg function and differentiation (<xref ref-type="bibr" rid="B65">65</xref>) and that IFN-&#x003B3; was upregulated in the infectious foci of <italic>L. infantum</italic> (Figures <xref ref-type="fig" rid="F3">3</xref>A&#x02013;F), we next evaluated whether the Th1-induced inflammation observed in the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice could be related to compromised Treg functions during infection. The results showed that following the infection, the frequency of CD4<sup>&#x0002B;</sup> T Foxp3<sup>&#x0002B;</sup> cells were reduced in both infected groups at fourth wpi compared with respective na&#x000EF;ve littermate control group. However, the reduction of CD4<sup>&#x0002B;</sup> T Foxp3<sup>&#x0002B;</sup> cells was more pronounced on A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice when compared to infected WT mice (Figures <xref ref-type="fig" rid="F6">6</xref>A,B). In terms of total cells, despite the infection promoting CD4<sup>&#x0002B;</sup> T Foxp3<sup>&#x0002B;</sup> cells expansion on both infected groups at fourth wpi, it was reduced on infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice when compared to infected WT compared with respective non-infected littermate controls (Figures <xref ref-type="fig" rid="F6">6</xref>A,B). Moreover, <italic>foxp3</italic> mRNA expression was reduced in the livers of A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice (Figure <xref ref-type="fig" rid="F6">6</xref>C). We previously demonstrated that adenosine provided an anti-inflammatory activity through a mechanism that was dependent on PGE<sub>2</sub>-induced IL-10 release (<xref ref-type="bibr" rid="B29">29</xref>). Consistent with the observed Treg reduction, the transcripts of IL-10, an important anti-inflammatory cytokine that is released through A<sub>2A</sub>R signaling, was reduced in the spleens at fourth wpi (Figure <xref ref-type="fig" rid="F6">6</xref>E) and livers at sixth wpi (Figure <xref ref-type="fig" rid="F6">6</xref>F) of the knockout mice. We observed a similar inhibition in the IL-10 release into supernatants of the <italic>L. infantum</italic> antigen-stimulated spleen leukocytes from the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice compared with the stimulated cells from the infected WT mice (Figure <xref ref-type="fig" rid="F6">6</xref>D).</p>
<fig id="F6" position="float">
<label>Figure 6</label>
<caption><p>A<sub>2A</sub>R induces the regulatory T cell population and IL-10 production during <italic>Leishmania infantum</italic> infection. In <bold>(A)</bold> representative dot plots of CD4<sup>&#x0002B;</sup> FOXP3<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup> cells in spleen of infected WT or A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> are shown in each box. The frequencies and absolute numbers of splenic CD4<sup>&#x0002B;</sup> FOXP3<sup>&#x0002B;</sup> gated on CD3<sup>&#x0002B;</sup> cells in non-infected (n.i) and infected WT and A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice (white bars and black bars, respectively) at the fourth and sixth weeks post infection <bold>(B)</bold>. The levels of the mRNA for <italic>foxp3</italic> expression in the livers were determined by quantitative polymerase chain reaction <bold>(C)</bold>. The levels of IL-10 produced by the splenic cells cultured at different phases of infection in the presence or absence of <italic>L. infantum</italic> antigens are shown <bold>(D)</bold>. The <italic>il10</italic> expression in spleens <bold>(E)</bold> and livers <bold>(F)</bold> of the infected and non-infected groups is shown. The results are expressed as the means&#x02009;&#x000B1;&#x02009;SD. <sup>&#x00023;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the uninfected WT group, <sup>&#x00026;</sup><italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the non-infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> group, and &#x0002A;<italic>P</italic>&#x02009;&#x0003C;&#x02009;0.05 compared to the infected WT group.</p></caption>
<graphic xlink:href="fimmu-08-00815-g006.tif"/>
</fig>
</sec>
</sec>
<sec id="S4" sec-type="discussion">
<title>Discussion</title>
<p>This study revealed the role of A<sub>2A</sub>R in increasing the susceptibility to <italic>L. infantum</italic> infection during experimental VL. Herein, we demonstrated that the absence of A<sub>2A</sub>R in the susceptible lineage BALB/c mice increased the cellular immune reaction as shown histopathologically by raised increased areas of mature and empty granulomas into liver. To understand the role of A<sub>2A</sub>R signaling, we quantified lower parasite burden in the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice that was accompanied by stronger development of the Th1 pattern of immune response, as indicated by a higher frequency of IFN-&#x003B3;-producing T cells, increased iNOS expression in the spleens and livers, and decreased Treg numbers and IL-10 release.</p>
<p>Several lines of evidence have shown that the development of mature hepatic granulomas is strictly related to the parasite killing, in that it limits spreading of the parasites to the organs (<xref ref-type="bibr" rid="B66">66</xref>). Accordingly, the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice at the sixth wpi harbored fewer parasites in the livers, and this was related to the elevated numbers of mature granulomas and empty granulomas in the hepatic tissue. Conversely, the susceptibility of WT mice during <italic>L. infantum</italic> infection was accompanied by a higher frequency of no granuloma reactions in both analyzed periods. It is possible that this was due to a decreased capacity to generate the mature granulomas that limit the parasite spreading.</p>
<p>A major requirement for maturation of a granuloma is the IFN-&#x003B3; production (<xref ref-type="bibr" rid="B2">2</xref>, <xref ref-type="bibr" rid="B3">3</xref>). In this sense, the elevated ratio of mature granulomas reflected the increased cellular immune reaction in the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice, which presented a strong Th1 adaptive immune reaction during <italic>L. infantum</italic> infection. It is no surprise that during a <italic>Leishmania</italic> infection, IFN-&#x003B3; causes activation of the phagocytes and production of NO, a molecule that is importantly involved in parasite killing (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). However, it is important to note that the increased frequency of mature granulomas was directly accompanied by increased areas of NOS2 staining in the liver, which reflects the importance of IFN-&#x003B3; in limiting the hepatic infection.</p>
<p>It has been demonstrated that A<sub>2A</sub>R is upregulated after T lymphocyte activation (<xref ref-type="bibr" rid="B25">25</xref>) and attenuates T cell response against cognate stimuli (<xref ref-type="bibr" rid="B27">27</xref>). Accordingly, the induction of experimental VL in A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice resulted in an increased Th1&#x02009;cell frequency during the infection as well as an attenuated response of the splenocytes to <italic>ex vivo</italic> stimulation with <italic>L. infantum</italic> antigen as demonstrated by lower levels of IFN-&#x003B3; production. Thus, these data could explain the reduced areas of the no granuloma reactions and the increased areas of both mature and empty granulomas on A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice, which reflected the high expression of iNOS into target organs.</p>
<p>The neutrophil recruitment to the VL-infected organs is crucial to controlling the parasite replication (<xref ref-type="bibr" rid="B67">67</xref>). Our data demonstrated that the infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice displayed an enhanced migration of activated neutrophils into the infected foci, a phenomenon that was accompanied by an increased capacity to control the spreading of the parasites into target organs. It has been shown that Th1 pattern-derived cytokines upregulate A<sub>2A</sub>R on phagocytes (<xref ref-type="bibr" rid="B68">68</xref>). This receptor is mainly involved with inhibition of cell migration, ROS production, and phagocytic activity (<xref ref-type="bibr" rid="B20">20</xref>, <xref ref-type="bibr" rid="B22">22</xref>, <xref ref-type="bibr" rid="B69">69</xref>). Interestingly, the absence of A<sub>2A</sub>R upregulated the expression of the neutrophil chemoattractant <italic>Cxcl1</italic> and its receptor CXCR2 on neutrophils, all of which are events that are involved in neutrophil recruitment. Regarding the activation, CD69 was highly expressed on neutrophils from infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice, a phenomenon that could be related to the IFN-&#x003B3; release (<xref ref-type="bibr" rid="B62">62</xref>, <xref ref-type="bibr" rid="B63">63</xref>). Curiously, not only was neutrophil activation abrogated after IFN-&#x003B3; depletion but also their recruitment was affected in the infected A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice, and this was accompanied by decreased CXCR2 expression. This result demonstrated that the A<sub>2A</sub>R-mediated regulation of neutrophil recruitment during the <italic>L. infantum</italic> infection resulted from the ability of this receptor to attenuate the Th1 immune response.</p>
<p>In addition to repressing the development of the Th1 immune response, A<sub>2A</sub>R signaling closely associated with the generation of Tregs and the improvement of their suppressor activity by stabilizing FOXP3 expression and inducing the CTLA-4-mediated suppressive effects (<xref ref-type="bibr" rid="B28">28</xref>). It is well established in the literature that suppression by the Tregs culminates in susceptibility to infection in several experimental models, including <italic>Leishmania</italic> (<xref ref-type="bibr" rid="B70">70</xref>). Accordingly, we demonstrated that the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice had a reduced frequency of Tregs during infection. It is also known that the Tregs represent a relevant source of adenosine through the action of the ectonucleotidases CD39 and CD73 (<xref ref-type="bibr" rid="B71">71</xref>). In addition to expanding the regulatory T cell repertoire, several lines of evidence highlight the importance of A<sub>2A</sub>R in the context of immune regulation in which it induces release of IL-10 by several types of leukocytes, including DCs, T cells, and Tregs (<xref ref-type="bibr" rid="B12">12</xref>, <xref ref-type="bibr" rid="B18">18</xref>, <xref ref-type="bibr" rid="B19">19</xref>, <xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B73">73</xref>). According to the literature, the lower levels of Tregs in A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice are accompanied by lower levels of <italic>il10</italic> mRNA in the organs targeted by the disease. Moreover, the splenocytes of these mice exhibited reduced IL-10 production <italic>ex vivo</italic> following stimulation with the parasite, which suggested that these mice presented an attenuated immunosuppressive potential during experimental VL (<xref ref-type="bibr" rid="B72">72</xref>, <xref ref-type="bibr" rid="B74">74</xref>, <xref ref-type="bibr" rid="B75">75</xref>). IL-10 is a potent anti-inflammatory cytokine that is strictly involved with VL progression by impairing the Th1&#x02009;cell responses, which abrogates the microbicidal mechanisms of the parasitized macrophages (<xref ref-type="bibr" rid="B76">76</xref>). Taking these data together, we hypothesize that the A<sub>2A</sub>R-mediated susceptibility in BALB/c mice is based in expanding the numbers of Tregs that, in turn, generate elevated levels of adenosine. This nucleoside may act in a positive feedback loop in which IL-10 is generated by Tregs in an autocrine fashion as well as in paracrine fashion by effector T cells. Moreover, we cannot exclude a role for DCs affecting the Th1&#x02009;cell polarization based on the recent observation by our group that adenosine, acting through A<sub>2A</sub>R, modulates DC activation as well as the T cell polarization toward to an anti-inflammatory phenotype (<xref ref-type="bibr" rid="B46">46</xref>). However, the implications of this process were not aimed in this work. We discard an intrinsic defect of A<sub>2A</sub>R signaling on Th1 driving, since CD4<sup>&#x0002B;</sup> T cells isolated from na&#x000EF;ve A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> under Th1 condition presented similar capacity to express T-bet transcriptional factor and IFN-&#x003B3; production than those of WT cells.</p>
<p>An important clinical outcome during VL is the development of hepatosplenomegaly (<xref ref-type="bibr" rid="B3">3</xref>). The evaluation of the weights of these target organs during the experimental infection revealed that the spleens and livers of the A<sub>2A</sub>R<sup>&#x02212;/&#x02212;</sup> mice were enlarged compared to the WT counterparts. Thus, we suggest that this phenomenon could be a result of the strong inflammatory response that favored the elimination of the parasites. In agreement with this result, our group observed that <italic>Il17ra<sup>&#x02212;/&#x02212;</sup></italic> mice, which were more susceptible to infection by <italic>L. infantum</italic>, exhibited less hepatosplenomegaly than the resistant WT group (<xref ref-type="bibr" rid="B7">7</xref>). Interestingly, CD4<sup>&#x0002B;</sup> T cells-producing IL-17 is also clinically associated with chronic inflammation seen in VL. Symptomatic patients showed a positive correlation between IL-17 and aspartate transaminase levels, indicating development of liver injury in those individuals (<xref ref-type="bibr" rid="B77">77</xref>). Therefore, the excessive inflammation triggered during VL could promote tissue damage (herein exemplified by organ enlargement) even though controlling parasite replication. Thus, we suggested adenosine signaling through A<sub>2A</sub>R limited the inflammation, controlling hepatosplenomegaly but it promotes parasite spread.</p>
<p>We conclude that A<sub>2A</sub>R is a negative regulator of the Th1 immune response, which may be due to an anti-inflammatory activity mediated by IL-10. In the absence of A<sub>2A</sub>R, BALB/c became resistant to <italic>L. infantum</italic> infection through an exacerbated Th1 immune response, which was responsible for recruiting neutrophils into the foci of the infection. Furthermore, we detected reduced regulatory T cell numbers and IL-10 production in the absence of A<sub>2A</sub>R signaling. Thus, we suggest that inhibition or blockade of A<sub>2A</sub>R could enhance the immune system effector functions to address persistent infections.</p>
</sec>
<sec id="S5">
<title>Ethics Statement</title>
<p>All experiments were conducted in accordance with the National Institutes of Health (NIH) guidelines on the welfare of experimental animals and with the approval of the Ethics Committee of the School of Medicine of Ribeir&#x000E3;o Preto (No 196/2011).</p>
</sec>
<sec id="S6" sec-type="author-contributor">
<title>Author Contributions</title>
<p>Conceived and designed the experiments: ML and VC. Performed the experiments: ML, LS, GQ, MF, AS, LB, and VC. Analyzed the data: ML and VC. Contributed reagents/materials/analysis tools: LB, FC, RA, JS, and VC. Wrote the paper: ML, GQ, and VC.</p>
</sec>
<sec id="S7">
<title>Conflict of Interest Statement</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</p>
</sec>
</body>
<back>
<fn-group>
<fn fn-type="financial-disclosure">
<p><bold>Funding</bold>. We are thankful to FAPESP and CNPq for their financial support. The research leading to these results has received funding from the S&#x000E3;o Paulo Research Foundation (FAPESP) under grant agreements No 15/12526-2 and No 2013/08216-2 (<italic>Center for Research in Inflammatory Disease</italic>) and NAP-DIN under grant agreement No <italic>11.1.21625.01.0</italic>, and Universal Project (CNPq) under agreement No 441424/2014-7 from the University of S&#x000E3;o Paulo.</p></fn>
</fn-group>
<sec id="S8" sec-type="supplementary-material">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at <uri xlink:href="http://journal.frontiersin.org/article/10.3389/fimmu.2017.00815/full&#x00023;supplementary-material">http://journal.frontiersin.org/article/10.3389/fimmu.2017.00815/full&#x00023;supplementary-material</uri>.</p>
<supplementary-material xlink:href="Data_Sheet_1.DOC" id="SM1" mimetype="applicationn/DOC" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mansueto</surname> <given-names>P</given-names></name> <name><surname>Seidita</surname> <given-names>A</given-names></name> <name><surname>Vitale</surname> <given-names>G</given-names></name> <name><surname>Cascio</surname> <given-names>A</given-names></name></person-group>. <article-title>Leishmaniasis in travelers: a literature review</article-title>. <source>Travel Med Infect Dis</source> (<year>2014</year>) <volume>12</volume>(<issue>6 Pt A</issue>):<fpage>563</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1016/j.tmaid.2014.09.007</pub-id></citation></ref>
<ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>HW</given-names></name></person-group>. <article-title>Tissue granuloma structure-function in experimental visceral leishmaniasis</article-title>. <source>Int J Exp Pathol</source> (<year>2001</year>) <volume>82</volume>(<issue>5</issue>):<fpage>249</fpage>&#x02013;<lpage>67</lpage>.<pub-id pub-id-type="doi">10.1046/j.1365-2613.2001.00199.x</pub-id><pub-id pub-id-type="pmid">11703536</pub-id></citation></ref>
<ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>HW</given-names></name> <name><surname>Berman</surname> <given-names>JD</given-names></name> <name><surname>Davies</surname> <given-names>CR</given-names></name> <name><surname>Saravia</surname> <given-names>NG</given-names></name></person-group>. <article-title>Advances in leishmaniasis</article-title>. <source>Lancet</source> (<year>2005</year>) <volume>366</volume>(<issue>9496</issue>):<fpage>1561</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="doi">10.1016/S0140-6736(05)67629-5</pub-id><pub-id pub-id-type="pmid">16257344</pub-id></citation></ref>
<ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Alvar</surname> <given-names>J</given-names></name> <name><surname>V&#x000E9;lez</surname> <given-names>ID</given-names></name> <name><surname>Bern</surname> <given-names>C</given-names></name> <name><surname>Herrero</surname> <given-names>M</given-names></name> <name><surname>Desjeux</surname> <given-names>P</given-names></name> <name><surname>Cano</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>Leishmaniasis worldwide and global estimates of its incidence</article-title>. <source>PLoS One</source> (<year>2012</year>) <volume>7</volume>(<issue>5</issue>):<fpage>e35671</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pone.0035671</pub-id><pub-id pub-id-type="pmid">22693548</pub-id></citation></ref>
<ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname> <given-names>FY</given-names></name> <name><surname>Millott</surname> <given-names>S</given-names></name> <name><surname>Parkinson</surname> <given-names>C</given-names></name> <name><surname>Palmer</surname> <given-names>RM</given-names></name> <name><surname>Moncada</surname> <given-names>S</given-names></name></person-group>. <article-title>Macrophage killing of <italic>Leishmania</italic> parasite in vivo is mediated by nitric oxide from <sc>l</sc>-arginine</article-title>. <source>J Immunol</source> (<year>1990</year>) <volume>144</volume>(<issue>12</issue>):<fpage>4794</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="pmid">2351828</pub-id></citation></ref>
<ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Liew</surname> <given-names>FY</given-names></name> <name><surname>Wei</surname> <given-names>XQ</given-names></name> <name><surname>Proudfoot</surname> <given-names>L</given-names></name></person-group>. <article-title>Cytokines and nitric oxide as effector molecules against parasitic infections</article-title>. <source>Philos Trans R Soc Lond B Biol Sci</source> (<year>1997</year>) <volume>352</volume>(<issue>1359</issue>):<fpage>1311</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1098/rstb.1997.0115</pub-id><pub-id pub-id-type="pmid">9355122</pub-id></citation></ref>
<ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nascimento</surname> <given-names>MS</given-names></name> <name><surname>Carregaro</surname> <given-names>V</given-names></name> <name><surname>Lima-J&#x000FA;nior</surname> <given-names>DS</given-names></name> <name><surname>Costa</surname> <given-names>DL</given-names></name> <name><surname>Ryffel</surname> <given-names>B</given-names></name> <name><surname>Duthie</surname> <given-names>MS</given-names></name> <etal/></person-group> <article-title>Interleukin 17A acts synergistically with interferon &#x003B3; to promote protection against <italic>Leishmania infantum</italic> infection</article-title>. <source>J Infect Dis</source> (<year>2015</year>) <volume>211</volume>(<issue>6</issue>):<fpage>1015</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiu531</pub-id></citation></ref>
<ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nylen</surname> <given-names>S</given-names></name> <name><surname>Sacks</surname> <given-names>D</given-names></name></person-group>. <article-title>Interleukin-10 and the pathogenesis of human visceral leishmaniasis</article-title>. <source>Trends Immunol</source> (<year>2007</year>) <volume>28</volume>(<issue>9</issue>):<fpage>378</fpage>&#x02013;<lpage>84</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2007.07.004</pub-id><pub-id pub-id-type="pmid">17689290</pub-id></citation></ref>
<ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carregaro</surname> <given-names>V</given-names></name> <name><surname>Napimoga</surname> <given-names>MH</given-names></name> <name><surname>Peres</surname> <given-names>RS</given-names></name> <name><surname>Benevides</surname> <given-names>L</given-names></name> <name><surname>Sacramento</surname> <given-names>LA</given-names></name> <name><surname>Pinto</surname> <given-names>LG</given-names></name> <etal/></person-group> <article-title>Therapeutic treatment of arthritic mice with 15-deoxy Delta12,14-prostaglandin J2 (15d-PGJ2) ameliorates disease through the suppression of Th17 cells and the induction of CD4&#x0002B;CD25-FOXP3&#x0002B; cells</article-title>. <source>Mediators Inflamm</source> (<year>2016</year>) <volume>2016</volume>:<fpage>9626427</fpage>.<pub-id pub-id-type="doi">10.1155/2016/9626427</pub-id></citation></ref>
<ref id="B10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chaves</surname> <given-names>MM</given-names></name> <name><surname>Canetti</surname> <given-names>C</given-names></name> <name><surname>Coutinho-Silva</surname> <given-names>R</given-names></name></person-group>. <article-title>Crosstalk between purinergic receptors and lipid mediators in leishmaniasis</article-title>. <source>Parasit Vectors</source> (<year>2016</year>) <volume>9</volume>(<issue>1</issue>):<fpage>489</fpage>.<pub-id pub-id-type="doi">10.1186/s13071-016-1781-1</pub-id><pub-id pub-id-type="pmid">27595742</pub-id></citation></ref>
<ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hask&#x000F3;</surname> <given-names>G</given-names></name> <name><surname>Linden</surname> <given-names>J</given-names></name> <name><surname>Cronstein</surname> <given-names>B</given-names></name> <name><surname>Pacher</surname> <given-names>P</given-names></name></person-group>. <article-title>Adenosine receptors: therapeutic aspects for inflammatory and immune diseases</article-title>. <source>Nat Rev Drug Discov</source> (<year>2008</year>) <volume>7</volume>(<issue>9</issue>):<fpage>759</fpage>&#x02013;<lpage>70</lpage>.<pub-id pub-id-type="doi">10.1038/nrd2638</pub-id><pub-id pub-id-type="pmid">18758473</pub-id></citation></ref>
<ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hask&#x000F3;</surname> <given-names>G</given-names></name> <name><surname>Cronstein</surname> <given-names>BN</given-names></name></person-group>. <article-title>Adenosine: an endogenous regulator of innate immunity</article-title>. <source>Trends Immunol</source> (<year>2004</year>) <volume>25</volume>(<issue>1</issue>):<fpage>33</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.it.2003.11.003</pub-id><pub-id pub-id-type="pmid">14698282</pub-id></citation></ref>
<ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burnstock</surname> <given-names>G</given-names></name></person-group>. <article-title>Purinergic signalling</article-title>. <source>Br J Pharmacol</source> (<year>2006</year>) <volume>147</volume>(<issue>Suppl 1</issue>):<fpage>S172</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1038/sj.bjp.0706429</pub-id><pub-id pub-id-type="pmid">16402102</pub-id></citation></ref>
<ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ralevic</surname> <given-names>V</given-names></name> <name><surname>Burnstock</surname> <given-names>G</given-names></name></person-group>. <article-title>Receptors for purines and pyrimidines</article-title>. <source>Pharmacol Rev</source> (<year>1998</year>) <volume>50</volume>(<issue>3</issue>):<fpage>413</fpage>&#x02013;<lpage>92</lpage>.</citation></ref>
<ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fredholm</surname> <given-names>BB</given-names></name> <name><surname>Arslan</surname> <given-names>G</given-names></name> <name><surname>Halldner</surname> <given-names>L</given-names></name> <name><surname>Kull</surname> <given-names>B</given-names></name> <name><surname>Schulte</surname> <given-names>G</given-names></name> <name><surname>Wasserman</surname> <given-names>W</given-names></name></person-group>. <article-title>Structure and function of adenosine receptors and their genes</article-title>. <source>Naunyn Schmiedebergs Arch Pharmacol</source> (<year>2000</year>) <volume>362</volume>(<issue>4&#x02013;5</issue>):<fpage>364</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1007/s002100000313</pub-id><pub-id pub-id-type="pmid">11111830</pub-id></citation></ref>
<ref id="B16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname> <given-names>A</given-names></name> <name><surname>Sitkovsky</surname> <given-names>M</given-names></name></person-group>. <article-title>Role of G-protein-coupled adenosine receptors in downregulation of inflammation and protection from tissue damage</article-title>. <source>Nature</source> (<year>2001</year>) <volume>414</volume>(<issue>6866</issue>):<fpage>916</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="doi">10.1038/414916a</pub-id><pub-id pub-id-type="pmid">11780065</pub-id></citation></ref>
<ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naganuma</surname> <given-names>M</given-names></name> <name><surname>Wiznerowicz</surname> <given-names>EB</given-names></name> <name><surname>Lappas</surname> <given-names>CM</given-names></name> <name><surname>Linden</surname> <given-names>J</given-names></name> <name><surname>Worthington</surname> <given-names>MT</given-names></name> <name><surname>Ernst</surname> <given-names>PB</given-names></name></person-group>. <article-title>Cutting edge: critical role for A2A adenosine receptors in the T cell-mediated regulation of colitis</article-title>. <source>J Immunol</source> (<year>2006</year>) <volume>177</volume>(<issue>5</issue>):<fpage>2765</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.177.5.2765</pub-id><pub-id pub-id-type="pmid">16920910</pub-id></citation></ref>
<ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hasko</surname> <given-names>G</given-names></name> <name><surname>Pacher</surname> <given-names>P</given-names></name></person-group>. <article-title>A2A receptors in inflammation and injury: lessons learned from transgenic animals</article-title>. <source>J Leukoc Biol</source> (<year>2008</year>) <volume>83</volume>(<issue>3</issue>):<fpage>447</fpage>&#x02013;<lpage>55</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0607359</pub-id><pub-id pub-id-type="pmid">18160539</pub-id></citation></ref>
<ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cs&#x000F3;ka</surname> <given-names>B</given-names></name> <name><surname>Selmeczy</surname> <given-names>Z</given-names></name> <name><surname>Koscs&#x000F3;</surname> <given-names>B</given-names></name> <name><surname>N&#x000E9;meth</surname> <given-names>ZH</given-names></name> <name><surname>Pacher</surname> <given-names>P</given-names></name> <name><surname>Murray</surname> <given-names>PJ</given-names></name> <etal/></person-group> <article-title>Adenosine promotes alternative macrophage activation via A2A and A2B receptors</article-title>. <source>FASEB J</source> (<year>2012</year>) <volume>26</volume>(<issue>1</issue>):<fpage>376</fpage>&#x02013;<lpage>86</lpage>.<pub-id pub-id-type="doi">10.1096/fj.11-190934</pub-id><pub-id pub-id-type="pmid">21926236</pub-id></citation></ref>
<ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Salmon</surname> <given-names>JE</given-names></name> <name><surname>Cronstein</surname> <given-names>BN</given-names></name></person-group>. <article-title>Fc gamma receptor-mediated functions in neutrophils are modulated by adenosine receptor occupancy. A1 receptors are stimulatory and A2 receptors are inhibitory</article-title>. <source>J Immunol</source> (<year>1990</year>) <volume>145</volume>(<issue>7</issue>):<fpage>2235</fpage>&#x02013;<lpage>40</lpage>.</citation></ref>
<ref id="B21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cronstein</surname> <given-names>BN</given-names></name> <name><surname>Daguma</surname> <given-names>L</given-names></name> <name><surname>Nichols</surname> <given-names>D</given-names></name> <name><surname>Hutchison</surname> <given-names>AJ</given-names></name> <name><surname>Williams</surname> <given-names>M</given-names></name></person-group>. <article-title>The adenosine/neutrophil paradox resolved: human neutrophils possess both A1 and A2 receptors that promote chemotaxis and inhibit O2 generation, respectively</article-title>. <source>J Clin Invest</source> (<year>1990</year>) <volume>85</volume>(<issue>4</issue>):<fpage>1150</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1172/JCI114547</pub-id><pub-id pub-id-type="pmid">2156895</pub-id></citation></ref>
<ref id="B22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fredholm</surname> <given-names>BB</given-names></name> <name><surname>Zhang</surname> <given-names>Y</given-names></name> <name><surname>van der Ploeg</surname> <given-names>I</given-names></name></person-group>. <article-title>Adenosine A2A receptors mediate the inhibitory effect of adenosine on formyl-Met-Leu-Phe-stimulated respiratory burst in neutrophil leucocytes</article-title>. <source>Naunyn Schmiedebergs Arch Pharmacol</source> (<year>1996</year>) <volume>354</volume>(<issue>3</issue>):<fpage>262</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1007/BF00171056</pub-id><pub-id pub-id-type="pmid">8878055</pub-id></citation></ref>
<ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fredholm</surname> <given-names>BB</given-names></name></person-group>. <article-title>Purines and neutrophil leukocytes</article-title>. <source>Gen Pharmacol</source> (<year>1997</year>) <volume>28</volume>(<issue>3</issue>):<fpage>345</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/S0306-3623(96)00169-3</pub-id></citation></ref>
<ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Save</surname> <given-names>S</given-names></name> <name><surname>Mohlin</surname> <given-names>C</given-names></name> <name><surname>Vumma</surname> <given-names>R</given-names></name> <name><surname>Persson</surname> <given-names>K</given-names></name></person-group>. <article-title>Activation of adenosine A2A receptors inhibits neutrophil transuroepithelial migration</article-title>. <source>Infect Immun</source> (<year>2011</year>) <volume>79</volume>(<issue>8</issue>):<fpage>3431</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.05005-11</pub-id><pub-id pub-id-type="pmid">21646447</pub-id></citation></ref>
<ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lappas</surname> <given-names>CM</given-names></name> <name><surname>Rieger</surname> <given-names>JM</given-names></name> <name><surname>Linden</surname> <given-names>J</given-names></name></person-group>. <article-title>A2A adenosine receptor induction inhibits IFN-gamma production in murine CD4&#x0002B; T cells</article-title>. <source>J Immunol</source> (<year>2005</year>) <volume>174</volume>(<issue>2</issue>):<fpage>1073</fpage>&#x02013;<lpage>80</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.174.2.1073</pub-id><pub-id pub-id-type="pmid">15634932</pub-id></citation></ref>
<ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bruzzese</surname> <given-names>L</given-names></name> <name><surname>Fromonot</surname> <given-names>J</given-names></name> <name><surname>By</surname> <given-names>Y</given-names></name> <name><surname>Durand-Gorde</surname> <given-names>JM</given-names></name> <name><surname>Condo</surname> <given-names>J</given-names></name> <name><surname>Kipson</surname> <given-names>N</given-names></name> <etal/></person-group> <article-title>NF-&#x003BA;B enhances hypoxia-driven T-cell immunosuppression via upregulation of adenosine A(2A) receptors</article-title>. <source>Cell Signal</source> (<year>2014</year>) <volume>26</volume>(<issue>5</issue>):<fpage>1060</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.cellsig.2014.01.024</pub-id><pub-id pub-id-type="pmid">24486403</pub-id></citation></ref>
<ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zarek</surname> <given-names>PE</given-names></name> <name><surname>Huang</surname> <given-names>CT</given-names></name> <name><surname>Lutz</surname> <given-names>ER</given-names></name> <name><surname>Kowalski</surname> <given-names>J</given-names></name> <name><surname>Horton</surname> <given-names>MR</given-names></name> <name><surname>Linden</surname> <given-names>J</given-names></name> <etal/></person-group> <article-title>A2A receptor signaling promotes peripheral tolerance by inducing T-cell anergy and the generation of adaptive regulatory T cells</article-title>. <source>Blood</source> (<year>2008</year>) <volume>111</volume>(<issue>1</issue>):<fpage>251</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2007-03-081646</pub-id><pub-id pub-id-type="pmid">17909080</pub-id></citation></ref>
<ref id="B28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohta</surname> <given-names>A</given-names></name> <name><surname>Kini</surname> <given-names>R</given-names></name> <name><surname>Ohta</surname> <given-names>A</given-names></name> <name><surname>Subramanian</surname> <given-names>M</given-names></name> <name><surname>Madasu</surname> <given-names>M</given-names></name> <name><surname>Sitkovsky</surname> <given-names>M</given-names></name></person-group>. <article-title>The development and immunosuppressive functions of CD4(&#x0002B;) CD25(&#x0002B;) FoxP3(&#x0002B;) regulatory T cells are under influence of the adenosine-A2A adenosine receptor pathway</article-title>. <source>Front Immunol</source> (<year>2012</year>) <volume>3</volume>:<fpage>190</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2012.00190</pub-id><pub-id pub-id-type="pmid">22783261</pub-id></citation></ref>
<ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carregaro</surname> <given-names>V</given-names></name> <name><surname>Sa-Nunes</surname> <given-names>A</given-names></name> <name><surname>Cunha</surname> <given-names>TM</given-names></name> <name><surname>Grespan</surname> <given-names>R</given-names></name> <name><surname>Oliveira</surname> <given-names>CJ</given-names></name> <name><surname>Lima-Junior</surname> <given-names>DS</given-names></name> <etal/></person-group> <article-title>Nucleosides from <italic>Phlebotomus papatasi</italic> salivary gland ameliorate murine collagen-induced arthritis by impairing dendritic cell functions</article-title>. <source>J Immunol</source> (<year>2011</year>) <volume>187</volume>(<issue>8</issue>):<fpage>4347</fpage>&#x02013;<lpage>59</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1003404</pub-id><pub-id pub-id-type="pmid">21930966</pub-id></citation></ref>
<ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tasca</surname> <given-names>T</given-names></name> <name><surname>Bonan</surname> <given-names>CD</given-names></name> <name><surname>De Carli</surname> <given-names>GA</given-names></name> <name><surname>Sarkis</surname> <given-names>JJ</given-names></name> <name><surname>Alderete</surname> <given-names>JF</given-names></name></person-group>. <article-title>Heterogeneity in extracellular nucleotide hydrolysis among clinical isolates of <italic>Trichomonas vaginalis</italic></article-title>. <source>Parasitology</source> (<year>2005</year>) <volume>131</volume>(<issue>Pt 1</issue>):<fpage>71</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1017/S0031182005007377</pub-id><pub-id pub-id-type="pmid">16038398</pub-id></citation></ref>
<ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Santos</surname> <given-names>RF</given-names></name> <name><surname>Possa</surname> <given-names>MA</given-names></name> <name><surname>Bastos</surname> <given-names>MS</given-names></name> <name><surname>Guedes</surname> <given-names>PM</given-names></name> <name><surname>Almeida</surname> <given-names>MR</given-names></name> <name><surname>Demarco</surname> <given-names>R</given-names></name> <etal/></person-group> <article-title>Influence of ecto-nucleoside triphosphate diphosphohydrolase activity on <italic>Trypanosoma cruzi</italic> infectivity and virulence</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2009</year>) <volume>3</volume>(<issue>3</issue>):<fpage>e387</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0000387</pub-id><pub-id pub-id-type="pmid">19255624</pub-id></citation></ref>
<ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de Souza</surname> <given-names>MC</given-names></name> <name><surname>de Assis</surname> <given-names>EA</given-names></name> <name><surname>Gomes</surname> <given-names>RS</given-names></name> <name><surname>Marques da Silva Ede</surname> <given-names>A</given-names></name> <name><surname>Melo</surname> <given-names>MN</given-names></name> <name><surname>Fietto</surname> <given-names>JL</given-names></name> <etal/></person-group> <article-title>The influence of ecto-nucleotidases on <italic>Leishmania amazonensis</italic> infection and immune response in C57B/6 mice</article-title>. <source>Acta Trop</source> (<year>2010</year>) <volume>115</volume>(<issue>3</issue>):<fpage>262</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/j.actatropica.2010.04.007</pub-id><pub-id pub-id-type="pmid">20399737</pub-id></citation></ref>
<ref id="B33"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo-Abrahao</surname> <given-names>T</given-names></name> <name><surname>Cosentino-Gomes</surname> <given-names>D</given-names></name> <name><surname>Daflon-Yunes</surname> <given-names>N</given-names></name> <name><surname>Meyer-Fernandes</surname> <given-names>JR</given-names></name></person-group>. <article-title><italic>Giardia duodenalis</italic>: biochemical characterization of an ecto-5&#x02019;-nucleotidase activity</article-title>. <source>Exp Parasitol</source> (<year>2011</year>) <volume>127</volume>(<issue>1</issue>):<fpage>66</fpage>&#x02013;<lpage>71</lpage>.<pub-id pub-id-type="doi">10.1016/j.exppara.2010.06.028</pub-id></citation></ref>
<ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paletta-Silva</surname> <given-names>R</given-names></name> <name><surname>Meyer-Fernandes</surname> <given-names>JR</given-names></name></person-group>. <article-title>Adenosine and immune imbalance in visceral leishmaniasis: the possible role of ectonucleotidases</article-title>. <source>J Trop Med</source> (<year>2012</year>) <volume>2012</volume>:<fpage>650874</fpage>.<pub-id pub-id-type="doi">10.1155/2012/650874</pub-id><pub-id pub-id-type="pmid">22007242</pub-id></citation></ref>
<ref id="B35"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Paletta-Silva</surname> <given-names>R</given-names></name> <name><surname>Vieira-Bernardo</surname> <given-names>R</given-names></name> <name><surname>Cosentino-Gomes</surname> <given-names>D</given-names></name> <name><surname>Meyer-Fernandes</surname> <given-names>JR</given-names></name></person-group>. <article-title><italic>Leishmania amazonensis</italic>: inhibition of 3&#x02019;-nucleotidase activity by Cu2&#x0002B; ions</article-title>. <source>Exp Parasitol</source> (<year>2012</year>) <volume>131</volume>(<issue>1</issue>):<fpage>63</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1016/j.exppara.2012.03.001</pub-id><pub-id pub-id-type="pmid">22449511</pub-id></citation></ref>
<ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahamed</surname> <given-names>DA</given-names></name> <name><surname>Toussaint</surname> <given-names>LE</given-names></name> <name><surname>Bynoe</surname> <given-names>MS</given-names></name></person-group>. <article-title>CD73-generated adenosine is critical for immune regulation during <italic>Toxoplasma gondii</italic> infection</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>(<issue>2</issue>):<fpage>721</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.02536-14</pub-id><pub-id pub-id-type="pmid">25452548</pub-id></citation></ref>
<ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russo-Abrahao</surname> <given-names>T</given-names></name> <name><surname>Cosentino-Gomes</surname> <given-names>D</given-names></name> <name><surname>Gomes</surname> <given-names>MT</given-names></name> <name><surname>Alviano</surname> <given-names>DS</given-names></name> <name><surname>Alviano</surname> <given-names>CS</given-names></name> <name><surname>Lopes</surname> <given-names>AH</given-names></name> <etal/></person-group> <article-title>Biochemical properties of <italic>Candida parapsilosis</italic> ecto-5&#x02019;-nucleotidase and the possible role of adenosine in macrophage interaction</article-title>. <source>FEMS Microbiol Lett</source> (<year>2011</year>) <volume>317</volume>(<issue>1</issue>):<fpage>34</fpage>&#x02013;<lpage>42</lpage>.<pub-id pub-id-type="doi">10.1111/j.1574-6968.2011.02216.x</pub-id></citation></ref>
<ref id="B38"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sansom</surname> <given-names>FM</given-names></name> <name><surname>Newton</surname> <given-names>HJ</given-names></name> <name><surname>Crikis</surname> <given-names>S</given-names></name> <name><surname>Cianciotto</surname> <given-names>NP</given-names></name> <name><surname>Cowan</surname> <given-names>PJ</given-names></name> <name><surname>d&#x02019;Apice</surname> <given-names>AJ</given-names></name> <etal/></person-group> <article-title>A bacterial ecto-triphosphate diphosphohydrolase similar to human CD39 is essential for intracellular multiplication of <italic>Legionella pneumophila</italic></article-title>. <source>Cell Microbiol</source> (<year>2007</year>) <volume>9</volume>(<issue>8</issue>):<fpage>1922</fpage>&#x02013;<lpage>35</lpage>.<pub-id pub-id-type="doi">10.1111/j.1462-5822.2007.00924.x</pub-id><pub-id pub-id-type="pmid">17388784</pub-id></citation></ref>
<ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thammavongsa</surname> <given-names>V</given-names></name> <name><surname>Kern</surname> <given-names>JW</given-names></name> <name><surname>Missiakas</surname> <given-names>DM</given-names></name> <name><surname>Schneewind</surname> <given-names>O</given-names></name></person-group>. <article-title><italic>Staphylococcus aureus</italic> synthesizes adenosine to escape host immune responses</article-title>. <source>J Exp Med</source> (<year>2009</year>) <volume>206</volume>(<issue>11</issue>):<fpage>2417</fpage>&#x02013;<lpage>27</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20090097</pub-id><pub-id pub-id-type="pmid">19808256</pub-id></citation></ref>
<ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Theatre</surname> <given-names>E</given-names></name> <name><surname>Frederix</surname> <given-names>K</given-names></name> <name><surname>Guilmain</surname> <given-names>W</given-names></name> <name><surname>Delierneux</surname> <given-names>C</given-names></name> <name><surname>Lecut</surname> <given-names>C</given-names></name> <name><surname>Bettendorff</surname> <given-names>L</given-names></name> <etal/></person-group> <article-title>Overexpression of CD39 in mouse airways promotes bacteria-induced inflammation</article-title>. <source>J Immunol</source> (<year>2012</year>) <volume>189</volume>(<issue>4</issue>):<fpage>1966</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.4049/jimmunol.1102600</pub-id><pub-id pub-id-type="pmid">22802412</pub-id></citation></ref>
<ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Berriman</surname> <given-names>M</given-names></name> <name><surname>Haas</surname> <given-names>BJ</given-names></name> <name><surname>LoVerde</surname> <given-names>PT</given-names></name> <name><surname>Wilson</surname> <given-names>RA</given-names></name> <name><surname>Dillon</surname> <given-names>GP</given-names></name> <name><surname>Cerqueira</surname> <given-names>GC</given-names></name> <etal/></person-group> <article-title>The genome of the blood fluke <italic>Schistosoma mansoni</italic></article-title>. <source>Nature</source> (<year>2009</year>) <volume>460</volume>(<issue>7253</issue>):<fpage>352</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1038/nature08160</pub-id><pub-id pub-id-type="pmid">19606141</pub-id></citation></ref>
<ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname> <given-names>YP</given-names></name> <name><surname>Wu</surname> <given-names>ZD</given-names></name> <name><surname>Yang</surname> <given-names>LL</given-names></name> <name><surname>Sun</surname> <given-names>X</given-names></name> <name><surname>You</surname> <given-names>X</given-names></name> <name><surname>Yu</surname> <given-names>XB</given-names></name> <etal/></person-group> <article-title>Cloning, molecular characterization of a 13-kDa antigen from <italic>Schistosoma japonicum</italic>, Sj13, a putative salivary diagnosis candidate for <italic>Schistosomiasis japonica</italic></article-title>. <source>Parasitol Res</source> (<year>2009</year>) <volume>105</volume>(<issue>5</issue>):<fpage>1435</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1007/s00436-009-1575-x</pub-id></citation></ref>
<ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Peres-Sampaio</surname> <given-names>CE</given-names></name> <name><surname>Palumbo</surname> <given-names>ST</given-names></name> <name><surname>Meyer-Fernandes</surname> <given-names>JR</given-names></name></person-group>. <article-title>An ecto-ATPase activity present in <italic>Leishmania tropica</italic> stimulated by dextran sulfate</article-title>. <source>Z Naturforsch C</source> (<year>2001</year>) <volume>56</volume>(<issue>9&#x02013;10</issue>):<fpage>820</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1515/znc-2001-9-1023</pub-id><pub-id pub-id-type="pmid">11724389</pub-id></citation></ref>
<ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gomes</surname> <given-names>RS</given-names></name> <name><surname>de Carvalho</surname> <given-names>LC</given-names></name> <name><surname>de Souza Vasconcellos</surname> <given-names>R</given-names></name> <name><surname>Fietto</surname> <given-names>JL</given-names></name> <name><surname>Afonso</surname> <given-names>LC</given-names></name></person-group>. <article-title>E-NTPDase (ecto-nucleoside triphosphate diphosphohydrolase) of <italic>Leishmania amazonensis</italic> inhibits macrophage activation</article-title>. <source>Microbes Infect</source> (<year>2015</year>) <volume>17</volume>(<issue>4</issue>):<fpage>295</fpage>&#x02013;<lpage>303</lpage>.<pub-id pub-id-type="doi">10.1016/j.micinf.2014.12.009</pub-id><pub-id pub-id-type="pmid">25554487</pub-id></citation></ref>
<ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Figueiredo</surname> <given-names>AB</given-names></name> <name><surname>Souza-Testasicca</surname> <given-names>MC</given-names></name> <name><surname>Afonso</surname> <given-names>LC</given-names></name></person-group>. <article-title>Purinergic signaling and infection by <italic>Leishmania</italic>: a new approach to evasion of the immune response</article-title>. <source>Biomed J</source> (<year>2016</year>) <volume>39</volume>(<issue>4</issue>):<fpage>244</fpage>&#x02013;<lpage>50</lpage>.<pub-id pub-id-type="doi">10.1016/j.bj.2016.08.004</pub-id><pub-id pub-id-type="pmid">27793266</pub-id></citation></ref>
<ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Carregaro</surname> <given-names>V</given-names></name> <name><surname>Ribeiro</surname> <given-names>JM</given-names></name> <name><surname>Valenzuela</surname> <given-names>JG</given-names></name> <name><surname>Souza-J&#x000FA;nior</surname> <given-names>DL</given-names></name> <name><surname>Costa</surname> <given-names>DL</given-names></name> <name><surname>Oliveira</surname> <given-names>CJ</given-names></name> <etal/></person-group> <article-title>Nucleosides present on phlebotomine saliva induce immunossuppression and promote the infection establishment</article-title>. <source>PLoS Negl Trop Dis</source> (<year>2015</year>) <volume>9</volume>(<issue>4</issue>):<fpage>e0003600</fpage>.<pub-id pub-id-type="doi">10.1371/journal.pntd.0003600</pub-id><pub-id pub-id-type="pmid">25849562</pub-id></citation></ref>
<ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Matte</surname> <given-names>C</given-names></name> <name><surname>Olivier</surname> <given-names>M</given-names></name></person-group>. <article-title><italic>Leishmania</italic>-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators</article-title>. <source>J Infect Dis</source> (<year>2002</year>) <volume>185</volume>(<issue>5</issue>):<fpage>673</fpage>&#x02013;<lpage>81</lpage>.<pub-id pub-id-type="doi">10.1086/339260</pub-id><pub-id pub-id-type="pmid">11865425</pub-id></citation></ref>
<ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vieira</surname> <given-names>DP</given-names></name> <name><surname>Paletta-Silva</surname> <given-names>R</given-names></name> <name><surname>Saraiva</surname> <given-names>EM</given-names></name> <name><surname>Lopes</surname> <given-names>AH</given-names></name> <name><surname>Meyer-Fernandes</surname> <given-names>JR</given-names></name></person-group>. <article-title><italic>Leishmania chagasi</italic>: an ecto-3&#x02019;-nucleotidase activity modulated by inorganic phosphate and its possible involvement in parasite-macrophage interaction</article-title>. <source>Exp Parasitol</source> (<year>2011</year>) <volume>127</volume>(<issue>3</issue>):<fpage>702</fpage>&#x02013;<lpage>7</lpage>.<pub-id pub-id-type="doi">10.1016/j.exppara.2010.11.003</pub-id><pub-id pub-id-type="pmid">21111737</pub-id></citation></ref>
<ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rai</surname> <given-names>AK</given-names></name> <name><surname>Thakur</surname> <given-names>CP</given-names></name> <name><surname>Velpandian</surname> <given-names>T</given-names></name> <name><surname>Sharma</surname> <given-names>SK</given-names></name> <name><surname>Ghosh</surname> <given-names>B</given-names></name> <name><surname>Mitra</surname> <given-names>DK</given-names></name></person-group>. <article-title>High concentration of adenosine in human visceral leishmaniasis despite increased ADA and decreased CD73</article-title>. <source>Parasite Immunol</source> (<year>2011</year>) <volume>33</volume>(<issue>11</issue>):<fpage>632</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-3024.2011.01315.x</pub-id><pub-id pub-id-type="pmid">21729107</pub-id></citation></ref>
<ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vijay</surname> <given-names>M</given-names></name> <name><surname>Amit</surname> <given-names>A</given-names></name> <name><surname>Kumar</surname> <given-names>S</given-names></name> <name><surname>Dikhit</surname> <given-names>MR</given-names></name> <name><surname>Jha</surname> <given-names>PK</given-names></name> <name><surname>Singh</surname> <given-names>AK</given-names></name> <etal/></person-group> <article-title>Up regulation of A(2B) adenosine receptor on monocytes are crucially required for immune pathogenicity in Indian patients exposed to <italic>Leishmania donovani</italic></article-title>. <source>Cytokine</source> (<year>2016</year>) <volume>79</volume>:<fpage>38</fpage>&#x02013;<lpage>44</lpage>.<pub-id pub-id-type="doi">10.1016/j.cyto.2015.12.016</pub-id></citation></ref>
<ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Titus</surname> <given-names>RG</given-names></name> <name><surname>Ceredig</surname> <given-names>R</given-names></name> <name><surname>Cerottini</surname> <given-names>JC</given-names></name> <name><surname>Louis</surname> <given-names>JA</given-names></name></person-group>. <article-title>Therapeutic effect of anti-L3T4 monoclonal antibody GK1.5 on cutaneous leishmaniasis in genetically-susceptible BALB/c mice</article-title>. <source>J Immunol</source> (<year>1985</year>) <volume>135</volume>(<issue>3</issue>):<fpage>2108</fpage>&#x02013;<lpage>14</lpage>.<pub-id pub-id-type="pmid">3926895</pub-id></citation></ref>
<ref id="B52"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Buffet</surname> <given-names>PA</given-names></name> <name><surname>Sulahian</surname> <given-names>A</given-names></name> <name><surname>Garin</surname> <given-names>YJ</given-names></name> <name><surname>Nassar</surname> <given-names>N</given-names></name> <name><surname>Derouin</surname> <given-names>F</given-names></name></person-group>. <article-title>Culture microtitration: a sensitive method for quantifying <italic>Leishmania infantum</italic> in tissues of infected mice</article-title>. <source>Antimicrob Agents Chemother</source> (<year>1995</year>) <volume>39</volume>(<issue>9</issue>):<fpage>2167</fpage>&#x02013;<lpage>8</lpage>.<pub-id pub-id-type="doi">10.1128/AAC.39.9.2167</pub-id><pub-id pub-id-type="pmid">8540741</pub-id></citation></ref>
<ref id="B53"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oghumu</surname> <given-names>S</given-names></name> <name><surname>Gupta</surname> <given-names>G</given-names></name> <name><surname>Snider</surname> <given-names>HM</given-names></name> <name><surname>Varikuti</surname> <given-names>S</given-names></name> <name><surname>Terrazas</surname> <given-names>CA</given-names></name> <name><surname>Papenfuss</surname> <given-names>TL</given-names></name> <etal/></person-group> <article-title>STAT4 is critical for immunity but not for antileishmanial activity of antimonials in experimental visceral leishmaniasis</article-title>. <source>Eur J Immunol</source> (<year>2014</year>) <volume>44</volume>(<issue>2</issue>):<fpage>450</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1002/eji.201343477</pub-id><pub-id pub-id-type="pmid">24242758</pub-id></citation></ref>
<ref id="B54"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Olekhnovitch</surname> <given-names>R</given-names></name> <name><surname>Bousso</surname> <given-names>P</given-names></name></person-group>. <article-title>Induction, propagation, and activity of host nitric oxide: lessons from <italic>Leishmania</italic> infection</article-title>. <source>Trends Parasitol</source> (<year>2015</year>) <volume>31</volume>(<issue>12</issue>):<fpage>653</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1016/j.pt.2015.08.001</pub-id></citation></ref>
<ref id="B55"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thalhofer</surname> <given-names>CJ</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Sudan</surname> <given-names>B</given-names></name> <name><surname>Love-Homan</surname> <given-names>L</given-names></name> <name><surname>Wilson</surname> <given-names>ME</given-names></name></person-group>. <article-title>Leukocytes infiltrate the skin and draining lymph nodes in response to the protozoan <italic>Leishmania infantum</italic> chagasi</article-title>. <source>Infect Immun</source> (<year>2011</year>) <volume>79</volume>(<issue>1</issue>):<fpage>108</fpage>&#x02013;<lpage>17</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00338-10</pub-id><pub-id pub-id-type="pmid">20937764</pub-id></citation></ref>
<ref id="B56"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacramento</surname> <given-names>LA</given-names></name> <name><surname>Cunha</surname> <given-names>FQ</given-names></name> <name><surname>de Almeida</surname> <given-names>RP</given-names></name> <name><surname>da Silva</surname> <given-names>JS</given-names></name> <name><surname>Carregaro</surname> <given-names>V</given-names></name></person-group>. <article-title>Protective role of 5-lipoxigenase during <italic>Leishmania infantum</italic> infection is associated with Th17 subset</article-title>. <source>Biomed Res Int</source> (<year>2014</year>) <volume>2014</volume>:<fpage>264270</fpage>.<pub-id pub-id-type="doi">10.1155/2014/264270</pub-id><pub-id pub-id-type="pmid">25309905</pub-id></citation></ref>
<ref id="B57"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacramento</surname> <given-names>L</given-names></name> <name><surname>Trevelin</surname> <given-names>SC</given-names></name> <name><surname>Nascimento</surname> <given-names>MS</given-names></name> <name><surname>Lima-Junior</surname> <given-names>DS</given-names></name> <name><surname>Costa</surname> <given-names>DL</given-names></name> <name><surname>Almeida</surname> <given-names>RP</given-names></name> <etal/></person-group> <article-title>Toll-like receptor 9 signaling in dendritic cells regulates neutrophil recruitment to inflammatory foci following <italic>Leishmania infantum</italic> infection</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>(<issue>12</issue>):<fpage>4604</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00975-15</pub-id></citation></ref>
<ref id="B58"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barletta</surname> <given-names>KE</given-names></name> <name><surname>Ley</surname> <given-names>K</given-names></name> <name><surname>Mehrad</surname> <given-names>B</given-names></name></person-group>. <article-title>Regulation of neutrophil function by adenosine</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2012</year>) <volume>32</volume>(<issue>4</issue>):<fpage>856</fpage>&#x02013;<lpage>64</lpage>.<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.226845</pub-id><pub-id pub-id-type="pmid">22423037</pub-id></citation></ref>
<ref id="B59"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Shukla</surname> <given-names>A</given-names></name> <name><surname>Namiki</surname> <given-names>S</given-names></name> <name><surname>Insel</surname> <given-names>PA</given-names></name> <name><surname>Junger</surname> <given-names>WG</given-names></name></person-group>. <article-title>A putative osmoreceptor system that controls neutrophil function through the release of ATP, its conversion to adenosine, and activation of A2 adenosine and P2 receptors</article-title>. <source>J Leukoc Biol</source> (<year>2004</year>) <volume>76</volume>(<issue>1</issue>):<fpage>245</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0204066</pub-id><pub-id pub-id-type="pmid">15107462</pub-id></citation></ref>
<ref id="B60"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Corriden</surname> <given-names>R</given-names></name> <name><surname>Inoue</surname> <given-names>Y</given-names></name> <name><surname>Yip</surname> <given-names>L</given-names></name> <name><surname>Hashiguchi</surname> <given-names>N</given-names></name> <name><surname>Zinkernagel</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors</article-title>. <source>Science</source> (<year>2006</year>) <volume>314</volume>(<issue>5806</issue>):<fpage>1792</fpage>&#x02013;<lpage>5</lpage>.<pub-id pub-id-type="doi">10.1126/science.1132559</pub-id><pub-id pub-id-type="pmid">17170310</pub-id></citation></ref>
<ref id="B61"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corriden</surname> <given-names>R</given-names></name> <name><surname>Chen</surname> <given-names>Y</given-names></name> <name><surname>Inoue</surname> <given-names>Y</given-names></name> <name><surname>Beldi</surname> <given-names>G</given-names></name> <name><surname>Robson</surname> <given-names>SC</given-names></name> <name><surname>Insel</surname> <given-names>PA</given-names></name> <etal/></person-group> <article-title>Ecto-nucleoside triphosphate diphosphohydrolase 1 (E-NTPDase1/CD39) regulates neutrophil chemotaxis by hydrolyzing released ATP to adenosine</article-title>. <source>J Biol Chem</source> (<year>2008</year>) <volume>283</volume>(<issue>42</issue>):<fpage>28480</fpage>&#x02013;<lpage>6</lpage>.<pub-id pub-id-type="doi">10.1074/jbc.M800039200</pub-id><pub-id pub-id-type="pmid">18713747</pub-id></citation></ref>
<ref id="B62"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atzeni</surname> <given-names>F</given-names></name> <name><surname>Schena</surname> <given-names>M</given-names></name> <name><surname>Ongari</surname> <given-names>AM</given-names></name> <name><surname>Carrabba</surname> <given-names>M</given-names></name> <name><surname>Bonara</surname> <given-names>P</given-names></name> <name><surname>Minonzio</surname> <given-names>F</given-names></name> <etal/></person-group> <article-title>Induction of CD69 activation molecule on human neutrophils by GM-CSF, IFN-gamma, and IFN-alpha</article-title>. <source>Cell Immunol</source> (<year>2002</year>) <volume>220</volume>(<issue>1</issue>):<fpage>20</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1016/S0008-8749(03)00002-9</pub-id><pub-id pub-id-type="pmid">12718936</pub-id></citation></ref>
<ref id="B63"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Atzeni</surname> <given-names>F</given-names></name> <name><surname>Del Papa</surname> <given-names>N</given-names></name> <name><surname>Sarzi-Puttini</surname> <given-names>P</given-names></name> <name><surname>Bertolazzi</surname> <given-names>F</given-names></name> <name><surname>Minonzio</surname> <given-names>F</given-names></name> <name><surname>Capsoni</surname> <given-names>F</given-names></name></person-group>. <article-title>CD69 expression on neutrophils from patients with rheumatoid arthritis</article-title>. <source>Clin Exp Rheumatol</source> (<year>2004</year>) <volume>22</volume>(<issue>3</issue>):<fpage>331</fpage>&#x02013;<lpage>4</lpage>.<pub-id pub-id-type="pmid">15144128</pub-id></citation></ref>
<ref id="B64"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ellis</surname> <given-names>TN</given-names></name> <name><surname>Beaman</surname> <given-names>BL</given-names></name></person-group>. <article-title>Interferon-gamma activation of polymorphonuclear neutrophil function</article-title>. <source>Immunology</source> (<year>2004</year>) <volume>112</volume>(<issue>1</issue>):<fpage>2</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="doi">10.1111/j.1365-2567.2004.01849.x</pub-id><pub-id pub-id-type="pmid">15096178</pub-id></citation></ref>
<ref id="B65"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname> <given-names>J</given-names></name> <name><surname>Duramad</surname> <given-names>O</given-names></name> <name><surname>Perng</surname> <given-names>OA</given-names></name> <name><surname>Reiner</surname> <given-names>SL</given-names></name> <name><surname>Liu</surname> <given-names>YJ</given-names></name> <name><surname>Qin</surname> <given-names>FX</given-names></name></person-group>. <article-title>Antagonistic nature of T helper 1/2 developmental programs in opposing peripheral induction of Foxp3&#x0002B; regulatory T cells</article-title>. <source>Proc Natl Acad Sci U S A</source> (<year>2007</year>) <volume>104</volume>(<issue>46</issue>):<fpage>18169</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="doi">10.1073/pnas.0703642104</pub-id><pub-id pub-id-type="pmid">17978190</pub-id></citation></ref>
<ref id="B66"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moore</surname> <given-names>JW</given-names></name> <name><surname>Moyo</surname> <given-names>D</given-names></name> <name><surname>Beattie</surname> <given-names>L</given-names></name> <name><surname>Andrews</surname> <given-names>PS</given-names></name> <name><surname>Timmis</surname> <given-names>J</given-names></name> <name><surname>Kaye</surname> <given-names>PM</given-names></name></person-group>. <article-title>Functional complexity of the <italic>Leishmania</italic> granuloma and the potential of in silico modeling</article-title>. <source>Front Immunol</source> (<year>2013</year>) <volume>4</volume>:<fpage>35</fpage>.<pub-id pub-id-type="doi">10.3389/fimmu.2013.00035</pub-id><pub-id pub-id-type="pmid">23423646</pub-id></citation></ref>
<ref id="B67"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sacramento</surname> <given-names>L</given-names></name> <name><surname>Trevelin</surname> <given-names>SC</given-names></name> <name><surname>Nascimento</surname> <given-names>MS</given-names></name> <name><surname>Souza-J&#x000FA;nior</surname> <given-names>DL</given-names></name> <name><surname>Costa</surname> <given-names>DL</given-names></name> <name><surname>Almeida</surname> <given-names>RP</given-names></name> <etal/></person-group> <article-title>TLR9 signaling on dendritic cells regulates neutrophil recruitment to inflammatory foci following <italic>Leishmania infantum</italic> infection</article-title>. <source>Infect Immun</source> (<year>2015</year>) <volume>83</volume>(<issue>12</issue>):<fpage>4604</fpage>&#x02013;<lpage>16</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.00975-15</pub-id></citation></ref>
<ref id="B68"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fortin</surname> <given-names>A</given-names></name> <name><surname>Harbour</surname> <given-names>D</given-names></name> <name><surname>Fernandes</surname> <given-names>M</given-names></name> <name><surname>Borgeat</surname> <given-names>P</given-names></name> <name><surname>Bourgoin</surname> <given-names>S</given-names></name></person-group>. <article-title>Differential expression of adenosine receptors in human neutrophils: up-regulation by specific Th1 cytokines and lipopolysaccharide</article-title>. <source>J Leukoc Biol</source> (<year>2006</year>) <volume>79</volume>(<issue>3</issue>):<fpage>574</fpage>&#x02013;<lpage>85</lpage>.<pub-id pub-id-type="doi">10.1189/jlb.0505249</pub-id><pub-id pub-id-type="pmid">16387843</pub-id></citation></ref>
<ref id="B69"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cronstein</surname> <given-names>BN</given-names></name></person-group>. <article-title>Adenosine, an endogenous anti-inflammatory agent</article-title>. <source>J Appl Physiol (1985)</source> (<year>1994</year>) <volume>76</volume>(<issue>1</issue>):<fpage>5</fpage>&#x02013;<lpage>13</lpage>.</citation></ref>
<ref id="B70"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khadem</surname> <given-names>F</given-names></name> <name><surname>Gao</surname> <given-names>X</given-names></name> <name><surname>Mou</surname> <given-names>Z</given-names></name> <name><surname>Jia</surname> <given-names>P</given-names></name> <name><surname>Movassagh</surname> <given-names>H</given-names></name> <name><surname>Onyilagha</surname> <given-names>C</given-names></name> <etal/></person-group> <article-title>Hepatic stellate cells regulate liver immunity to visceral leishmaniasis through P110&#x003B4;-dependent induction and expansion of regulatory T cells in mice</article-title>. <source>Hepatology</source> (<year>2016</year>) <volume>63</volume>(<issue>2</issue>):<fpage>620</fpage>&#x02013;<lpage>32</lpage>.<pub-id pub-id-type="doi">10.1002/hep.28130</pub-id><pub-id pub-id-type="pmid">26289140</pub-id></citation></ref>
<ref id="B71"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Deaglio</surname> <given-names>S</given-names></name> <name><surname>Dwyer</surname> <given-names>KM</given-names></name> <name><surname>Gao</surname> <given-names>W</given-names></name> <name><surname>Friedman</surname> <given-names>D</given-names></name> <name><surname>Usheva</surname> <given-names>A</given-names></name> <name><surname>Erat</surname> <given-names>A</given-names></name> <etal/></person-group> <article-title>Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression</article-title>. <source>J Exp Med</source> (<year>2007</year>) <volume>204</volume>(<issue>6</issue>):<fpage>1257</fpage>&#x02013;<lpage>65</lpage>.<pub-id pub-id-type="doi">10.1084/jem.20062512</pub-id><pub-id pub-id-type="pmid">17502665</pub-id></citation></ref>
<ref id="B72"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cs&#x000F3;ka</surname> <given-names>B</given-names></name> <name><surname>N&#x000E9;meth</surname> <given-names>ZH</given-names></name> <name><surname>Vir&#x000E1;g</surname> <given-names>L</given-names></name> <name><surname>Gergely</surname> <given-names>P</given-names></name> <name><surname>Leibovich</surname> <given-names>SJ</given-names></name> <name><surname>Pacher</surname> <given-names>P</given-names></name> <etal/></person-group> <article-title>A2A adenosine receptors and C/EBPbeta are crucially required for IL-10 production by macrophages exposed to <italic>Escherichia coli</italic></article-title>. <source>Blood</source> (<year>2007</year>) <volume>110</volume>(<issue>7</issue>):<fpage>2685</fpage>&#x02013;<lpage>95</lpage>.<pub-id pub-id-type="doi">10.1182/blood-2007-01-065870</pub-id><pub-id pub-id-type="pmid">17525287</pub-id></citation></ref>
<ref id="B73"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hask&#x000F3;</surname> <given-names>G</given-names></name> <name><surname>Pacher</surname> <given-names>P</given-names></name></person-group>. <article-title>Regulation of macrophage function by adenosine</article-title>. <source>Arterioscler Thromb Vasc Biol</source> (<year>2012</year>) <volume>32</volume>(<issue>4</issue>):<fpage>865</fpage>&#x02013;<lpage>9</lpage>.<pub-id pub-id-type="doi">10.1161/ATVBAHA.111.226852</pub-id><pub-id pub-id-type="pmid">22423038</pub-id></citation></ref>
<ref id="B74"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Burnstock</surname> <given-names>G</given-names></name></person-group>. <article-title>Purinergic signalling: from discovery to current developments</article-title>. <source>Exp Physiol</source> (<year>2014</year>) <volume>99</volume>(<issue>1</issue>):<fpage>16</fpage>&#x02013;<lpage>34</lpage>.<pub-id pub-id-type="doi">10.1113/expphysiol.2013.071951</pub-id><pub-id pub-id-type="pmid">24078669</pub-id></citation></ref>
<ref id="B75"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Antonioli</surname> <given-names>L</given-names></name> <name><surname>Blandizzi</surname> <given-names>C</given-names></name> <name><surname>Cs&#x000F3;ka</surname> <given-names>B</given-names></name> <name><surname>Pacher</surname> <given-names>P</given-names></name> <name><surname>Hask&#x000F3;</surname> <given-names>G</given-names></name></person-group>. <article-title>Adenosine signalling in diabetes mellitus-pathophysiology and therapeutic considerations</article-title>. <source>Nat Rev Endocrinol</source> (<year>2015</year>) <volume>11</volume>(<issue>4</issue>):<fpage>228</fpage>&#x02013;<lpage>41</lpage>.<pub-id pub-id-type="doi">10.1038/nrendo.2015.10</pub-id></citation></ref>
<ref id="B76"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Murray</surname> <given-names>HW</given-names></name> <name><surname>Lu</surname> <given-names>CM</given-names></name> <name><surname>Mauze</surname> <given-names>S</given-names></name> <name><surname>Freeman</surname> <given-names>S</given-names></name> <name><surname>Moreira</surname> <given-names>AL</given-names></name> <name><surname>Kaplan</surname> <given-names>G</given-names></name> <etal/></person-group> <article-title>Interleukin-10 (IL-10) in experimental visceral leishmaniasis and IL-10 receptor blockade as immunotherapy</article-title>. <source>Infect Immun</source> (<year>2002</year>) <volume>70</volume>(<issue>11</issue>):<fpage>6284</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="doi">10.1128/IAI.70.11.6284-6293.2002</pub-id><pub-id pub-id-type="pmid">12379707</pub-id></citation></ref>
<ref id="B77"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nascimento</surname> <given-names>MS</given-names></name> <name><surname>Carregaro</surname> <given-names>V</given-names></name> <name><surname>Lima-Junior</surname> <given-names>DS</given-names></name> <name><surname>Costa</surname> <given-names>DL</given-names></name> <name><surname>Ryffel</surname> <given-names>B</given-names></name> <name><surname>Duthie</surname> <given-names>MS</given-names></name> <etal/></person-group> <article-title>Interleukin 17A acts synergistically with interferon gamma to promote protection against <italic>Leishmania infantum</italic> infection</article-title>. <source>J Infect Dis</source> (<year>2015</year>) <volume>211</volume>(<issue>6</issue>):<fpage>1015</fpage>&#x02013;<lpage>26</lpage>.<pub-id pub-id-type="doi">10.1093/infdis/jiu531</pub-id></citation></ref>
</ref-list>
</back>
</article>